School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Jeffrey Olson MD

  • Department of Neurosurgery
    Professor
  • (404) 778-5770
  • jolson@emory.edu
Head shot of Jeffrey Olson

Academic Appointment

  • Professor of Hematology and Medical Oncology, Emory University School of Medicine
  • Professor of Neurosurgery, Emory University School of Medicine

Education

Degrees

  • MD from University of Minnesota
  • BA from Concordia College

Research

Focus

  • Investigational therapies of brain tumors have been the primary thrust of my research. This includes analysis of new agents or modification of established regimens using brain tumor models in vitro and in vivo. A strong emphasis on clinical investigations has been maintained to provide for accomplishment of translational work.

Publications

  • Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.
    Br J Neurosurg Volume: 39 Page(s): 224 - 227
    04/01/2025 Authors: Mokhtari S; Peeri NC; Beer-Furlan A; Anderson MD; Chowdhary S; LaRocca RV; Mammoser AG; Nabors LB; Olson JJ; Thompson RC
  • Volumetric Analysis of Spheno-Orbital Meningiomas: Prognostic Correlation and a Compartmentalized Approach.
    Neurosurgery Volume: 94 Page(s): 736 - 744
    04/01/2024 Authors: Zohdy YM; Jacob F; Agam M; Alawieh A; Bray D; Barbero JMR; Argaw SA; Maldonado J; Rodas A; Sudhakar V
  • Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis.
    Cancers (Basel) Volume: 16
    01/18/2024 Authors: Mayol Del Valle M; Morales B; Philbrick B; Adeagbo S; Goyal S; Newman S; Frontera NL; Nduom E; Olson J; Neill S
  • Label- and slide-free tissue histology using 3D epi-mode quantitative phase imaging and virtual hematoxylin and eosin staining.
    Optica Volume: 10 Page(s): 1605 - 1618
    12/20/2023 Authors: Abraham TM; Casteleiro Costa P; Filan C; Guang Z; Zhang Z; Neill S; Olson JJ; Levenson R; Robles FE
  • Rationale for the Development of a Novel Clinical Grading Scale for Postoperative Facial Nerve Function: Results of a Multidisciplinary International Working Group.
    Otol Neurotol Volume: 44 Page(s): e747 - e754
    12/01/2023 Authors: Carlson ML; Lohse CM; Agazzi S; Babu SC; Barker FG; Barnett S; Bi WL; Biggs N; Boahene KD; Breen JT
  • Examining the Effect of ALK and EGFR Mutations on Survival Outcomes in Surgical Lung Brain Metastasis Patients.
    Cancers (Basel) Volume: 15
    09/28/2023 Authors: Mannam SS; Bray DP; Nwagwu CD; Zhong J; Shu H-K; Eaton B; Sudmeier L; Goyal S; Deibert C; Nduom EK
  • Immune microenvironment remodeling after radiation of a progressing brain metastasis.
    Cell Rep Med Volume: 4 Page(s): 101054
    06/20/2023 Authors: Hudson WH; Olson JJ; Sudmeier LJ
  • Label- and slide-free tissue histology using 3D epi-mode quantitative phase imaging and virtual H&E staining.
    ArXiv
    06/01/2023 Authors: Abraham TM; Costa PC; Filan C; Guang Z; Zhang Z; Neill S; Olson JJ; Levenson R; Robles FE
  • Using Brain Tumor MRI Structured Reporting to Quantify the Impact of Imaging on Brain Tumor Boards.
    Tomography Volume: 9 Page(s): 859 - 870
    04/18/2023 Authors: Abidi SA; Hoch MJ; Hu R; Sadigh G; Voloschin A; Olson JJ; Shu H-KG; Neill SG; Weinberg BD
  • Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS.
    Res Sq
    03/23/2023 Authors: Jansen CS; Prabhu RS; Pagadala MS; Chappa P; Goyal S; Zhou C; Neill SG; Prokhnevska N; Cardenas M; Hoang KB
  • Commentary: Stress, Anxiety, and Depression Associated With Awake Craniotomy: A Systematic Review.
    Neurosurgery Volume: 92 Page(s): e14
    02/01/2023 Authors: Rai SS; Olson JJ
  • Opioid-Free Anesthesia for Craniotomy.
    J Neurosurg Anesthesiol Volume: 35 Page(s): 80 - 85
    01/01/2023 Authors: McCullough IL; Shteamer JW; Erwood AM; Spektor B; Boorman DW; Sharifpour M; Olson JJ; Papangelou A
  • ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.
    J Neurooncol Volume: 161 Page(s): 33 - 43
    01/01/2023 Authors: Sloan AE; Nock CJ; Ye X; Buerki R; Chang S; Lesser G; Norden A; Cloughesy T; Olson J; Kerstetter-Fogle A
  • Letter to the Editor.
    J Neurooncol Volume: 160 Page(s): 341 - 343
    11/01/2022 Authors: Goodman A; Velazquez-Vega J; Olson J
  • Patterns of Treatment Failure in PCNSL
    Volume: 114 Page(s): E84 - E84
    11/01/2022 Authors: Patel J; Janopaul-Naylor J; Rupji M; Voloschin A; Hoang KB; Olson JJ; Shu HKG; Zhong J; Neill SG; Eaton BR
  • YAP/TAZ TRANSCRIPTIONAL CO-ACTIVATORS DRIVE NEURO-GLIAL STEM/PROGENITOR CELL IDENTITY IN HIGH GRADE GLIOMAS
    Volume: 24 Page(s): 101 - 101
    11/01/2022 Authors: Read R; Oh S-Y; Vigneswaran K; Boyd N; Young E; Read W; Olson J
  • EPIGENETIC REACTIVATION OF BAI1 SUPPRESSES TUMOR INVASION, RECURRENCE, AND SPINAL METASTASIS BY PREVENTING TGFB1-INDUCED MESENCHYMAL SWITCH IN GLIOBLASTOMA
    Volume: 24 Page(s): 2 - 2
    11/01/2022 Authors: Osuka S; Yang L; Hashimoto H; Zhu D; Zhang Z; Olson J; Devi N; Van Meir E
  • Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy.
    Radiother Oncol Volume: 175 Page(s): 93 - 100
    10/01/2022 Authors: Qian DC; Marascio JA; Tobillo R; Lorenz JW; McCall NS; Neill SG; Hoang KB; Olson JJ; Eaton BR; Shu H-KG
  • Adjuvant Radiotherapy in Grade II, Atypical Meningioma of the Skull Base.
    J Neurol Surg B Skull Base Volume: 83 Page(s): 418 - 422
    08/01/2022 Authors: Bray DP; Buster BE; Quillin JW; Press RH; Eaton BR; Olson JJ
  • 5-Aminolevulinic acid for enhanced surgical visualization of high-grade gliomas: a prospective, multicenter study.
    J Neurosurg Volume: 136 Page(s): 1525 - 1534
    06/01/2022 Authors: Schupper AJ; Baron RB; Cheung W; Rodriguez J; Kalkanis SN; Chohan MO; Andersen BJ; Chamoun R; Nahed BV; Zacharia BE
  • Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults.
    J Neurooncol Volume: 158 Page(s): 139 - 165
    06/01/2022 Authors: Johnson DR; Glenn CA; Javan R; Olson JJ
  • Congress of Neurological Surgeons systematic review and evidence-based guidelines for the treatment of adults with progressive glioblastoma update: introduction and methods.
    J Neurooncol Volume: 158 Page(s): 133 - 137
    06/01/2022 Authors: Olson JJ
  • Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma.
    J Neurooncol Volume: 158 Page(s): 265 - 321
    06/01/2022 Authors: Winograd E; Germano I; Wen P; Olson JJ; Ormond DR
  • Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults.
    J Neurooncol Volume: 158 Page(s): 255 - 264
    06/01/2022 Authors: Ziu M; Goyal S; Olson JJ
  • Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults.
    J Neurooncol Volume: 158 Page(s): 225 - 253
    06/01/2022 Authors: Germano IM; Ziu M; Wen P; Ormond DR; Olson JJ
  • Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults.
    J Neurooncol Volume: 158 Page(s): 167 - 177
    06/01/2022 Authors: Patrick HH; Sherman JH; Elder JB; Olson JJ
  • Commentary: Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain Metastasis.
    Neurosurgery Volume: 90 Page(s): e142 - e143
    06/01/2022 Authors: Del Valle MM; Nduom EK; Olson J; Hoang KB
  • Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.
    J Neurooncol Volume: 158 Page(s): 179 - 224
    06/01/2022 Authors: Goodman AL; Velzquez Vega JE; Glenn C; Olson JJ
  • Distinct phenotypic states and spatial distribution of CD8+ Tcell clonotypes in human brain metastases.
    Cell Rep Med Volume: 3 Page(s): 100620
    05/17/2022 Authors: Sudmeier LJ; Hoang KB; Nduom EK; Wieland A; Neill SG; Schniederjan MJ; Ramalingam SS; Olson JJ; Ahmed R; Hudson WH
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Management of Progressive Glioblastoma in Adults: Update of the 2014 Guidelines.
    Neurosurgery Volume: 90 Page(s): e112 - e115
    05/01/2022 Authors: Germano IM; Johnson DR; Patrick HH; Goodman AL; Ziu M; Ormond DR; Olson JJ
  • Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma.
    Tomography Volume: 8 Page(s): 688 - 700
    03/03/2022 Authors: Xu K; Ramesh K; Huang V; Gurbani SS; Cordova JS; Schreibmann E; Weinberg BD; Sengupta S; Voloschin AD; Holdhoff M
  • Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review.
    J Neurooncol Volume: 157 Page(s): 187 - 195
    03/01/2022 Authors: Grogan D; Bray DP; Cosgrove M; Boucher A; Erwood A; Linder DF; Mendoza P; Morales B; Pradilla G; Nduom EK
  • 82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis.
    Q J Nucl Med Mol Imaging Volume: 66 Page(s): 74 - 81
    03/01/2022 Authors: Parent EE; Sethi I; Nye J; Holder C; Olson JJ; Switchenko J; Tade F; Akin-Akintayo OO; Abiodun-Ojo OA; Akintayo A
  • Commentary: 5-Aminolevulinic Acid-Induced Porphyrin Contents in Various Brain Tumors: Implications Regarding Imaging Device Design and Their Validation.
    Neurosurgery Volume: 90 Page(s): e43 - e44
    02/01/2022 Authors: Bray DP; Hoang KB; Nduom EK; Olson JJ
  • Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.
    J Clin Oncol Volume: 40 Page(s): 403 - 426
    02/01/2022 Authors: Mohile NA; Messersmith H; Gatson NT; Hottinger AF; Lassman A; Morton J; Ney D; Nghiemphu PL; Olar A; Olson J
  • Artificial neural networks predict the need for permanent cerebrospinal fluid diversion following posterior fossa tumor resection.
    Neurooncol Adv Volume: 4 Page(s): vdac145
    01/01/2022 Authors: Bray DP; Saad H; Douglas JM; Grogan D; Dawoud RA; Chow J; Deibert C; Pradilla G; Nduom EK; Olson JJ
  • Permanent Cerebrospinal Fluid Diversion in Adults With Posterior Fossa Tumors: Incidence and Predictors.
    Neurosurgery Volume: 89 Page(s): 987 - 996
    11/18/2021 Authors: Saad H; Bray DP; McMahon JT; Philbrick BD; Dawoud RA; Douglas JM; Adeagbo S; Yarmoska SK; Agam M; Chow J
  • CHARACTERIZATION OF TUMOR-INFILTRATING CD8+T CELLS IN BRAIN METASTASES
    Volume: 23 Page(s): 91 - 92
    11/01/2021 Authors: Sudmeier L; Hudson W; Hoang K; Nduom E; Neill S; Schniederjan M; Olson J; Ahmed R
  • TREATMENT TRENDS AND SURVIVAL OUTCOMES IN ATYPICAL MENINGIOMA
    Volume: 23 Page(s): 48 - 48
    11/01/2021 Authors: Syed Y; Rupji M; Switchenko J; Eaton B; Olson J; Kimberly H; Bray D; Shu H-K; Zhong J
  • Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center.
    Cureus Volume: 13 Page(s): e19777
    11/01/2021 Authors: Warren KT; Boucher A; Bray DP; Dresser S; Zhong J; Shu H-K; Olson J; Hoang K
  • Defining the Immune Cell Infiltrate of Brain Metastases Before and After Stereotactic Radiosurgery
    Volume: 111 Page(s): E233 - E234
    11/01/2021 Authors: Sudmeier LJ; Hudson W; Hoang KB; Nduom E; Shu HKG; Higgins KA; Olson JJ; Ahmed R
  • Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases
    Volume: 111 Page(s): S25 - S25
    11/01/2021 Authors: Eaton BR; Chen Z; Butker EK; Gorgens U; Zhong J; Higgins KA; Patel PR; Bradley JD; Hoang KB; Nduom E
  • Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): S25
    11/01/2021 Authors: Eaton BR; Chen Z; Butker EK; Gorgens U; Zhong J; Higgins KA; Patel PR; Bradley JD; Hoang KB; Nduom E
  • Defining the Immune Cell Infiltrate of Brain Metastases Before and After Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e233 - e234
    11/01/2021 Authors: Sudmeier LJ; Hudson W; Hoang KB; Nduom E; Shu HKG; Higgins KA; Olson JJ; Ahmed R
  • In Reply: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
    Neurosurgery Volume: 89 Page(s): E279 - E280
    10/13/2021 Authors: Bray DP; Quillin JW; Press RH; Yang Y; Chen Z; Eaton BR; Olson JJ
  • Letter: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
    Neurosurgery Volume: 89 Page(s): E174 - E175
    08/16/2021 Authors: Bray DP; Quillin JW; Press RH; Yang Y; Chen Z; Eaton BR; Olson JJ
  • Label-free detection of brain tumors in a 9L gliosarcoma rat model using stimulated Raman scattering-spectroscopic optical coherence tomography.
    J Biomed Opt Volume: 26
    07/01/2021 Authors: Soltani S; Guang Z; Zhang Z; Olson J; Robles F
  • Synthesis, Radiolabeling, and Biological Evaluation of the trans-Stereoisomers of 1-Amino-3-(fluoro-18F)-4-fluorocyclopentane-1-carboxylic Acid as PET Imaging Agents.
    ACS Pharmacol Transl Sci Volume: 4 Page(s): 1195 - 1203
    06/11/2021 Authors: Pickel TC; Pashikanti G; Voll RJ; Yu W; Zhang Z; Nye JA; Bacsa J; Olson JJ; Liebeskind LS; Goodman MM
  • 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas.
    J Neurooncol Volume: 153 Page(s): 303 - 311
    06/01/2021 Authors: Zhong J; Huang V; Gurbani SS; Ramesh K; Scott Cordova J; Schreibmann E; Shu H-KG; Olson J; Han H; Giuffrida A
  • Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
    Neurosurgery Volume: 88 Page(s): E435 - E442
    04/15/2021 Authors: Bray DP; Quillin JW; Press RH; Yang Y; Chen Z; Eaton BR; Olson JJ
  • An immunologic niche of antigen presenting cells and stem-like CD8+T-cells is present in non-small cell lung cancer brain metastases.
    Volume: 27
    04/01/2021 Authors: Jansen CS; del Balzo L; Prabhu R; Logan S; Chappa P; Patel K; Wilkinson S; Lake R; Shu H-KG; Zhong J
  • N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
    Volume: 131
    03/15/2021 Authors: Osuka S; Zhu D; Zhang Z; Li C; Stackhouse CT; Sampetrean O; Olson JJ; Gillespie GY; Saya H; Willey CD
  • YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
    Clin Cancer Res Volume: 27 Page(s): 1553 - 1569
    03/01/2021 Authors: Vigneswaran K; Boyd NH; Oh S-Y; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
  • Towards in-vivo label-free detection of brain tumor margins with epi-illumination tomographic quantitative phase imaging.
    Biomed Opt Express Volume: 12 Page(s): 1621 - 1634
    03/01/2021 Authors: Costa PC; Guang Z; Ledwig P; Zhang Z; Neill S; Olson JJ; Robles FE
  • Guidelines in the management of CNS tumors.
    J Neurooncol Volume: 151 Page(s): 345 - 359
    02/01/2021 Authors: Redjal N; Venteicher AS; Dang D; Sloan A; Kessler RA; Baron RR; Hadjipanayis CG; Chen CC; Ziu M; Olson JJ
  • Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma.
    Case Rep Oncol Volume: 14 Page(s): 487 - 492
    01/01/2021 Authors: Qian DC; Weinberg BD; Neill SG; Goodman AL; Olson JJ; Voloschin AD; Ramalingam SS; Shu H-KG
  • [18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis.
    EJNMMI Res Volume: 10 Page(s): 148
    12/07/2020 Authors: Parent EE; Patel D; Nye JA; Li Z; Olson JJ; Schuster DM; Goodman MM
  • High-Grade Sarcoma Arising within a Previously Irradiated Vestibular Schwannoma: A Case Report and Literature Review.
    World Neurosurg Volume: 144 Page(s): 99 - 105
    12/01/2020 Authors: Boucher AB; Mendoza P; Neill SG; Eaton B; Olson JJ
  • Sheltered Neurosurgery During COVID-19: The Emory Experience.
    World Neurosurg Volume: 144 Page(s): e204 - e209
    12/01/2020 Authors: Saad H; Alawieh A; Oyesiku N; Barrow DL; Olson J
  • SUBJECT: AANS/CNS Endorsement of The Joint Section on Tumor's Newly Diagnosed Glioblastoma Guidelines Update
    JOURNAL OF NEURO-ONCOLOGY Volume: 150 Page(s): 85 - 85
    11/01/2020 Authors: Olson JJ; Wilson JA; Kalkanis SN; Aquino KH
  • UPDATES ON CLINICAL OUTCOMES AND TUMOR RECURRENCE PATTERNS OF A HUMAN PILOT STUDY ASSESSING EFFICACY OF BELINOSTAT (PXD-101) COMBINING WITH CHEMORADIATION IN TREATING GLIOBLASTOMA
    Volume: 22 Page(s): 44 - 44
    11/01/2020 Authors: Xu K; Huang V; Ramesh K; Gurbani S; Schreibmann E; Weinberg B; Sengupta S; Voloschin A; Holdhoff M; Barker P
  • Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.
    J Neurooncol Volume: 150 Page(s): 87 - 93
    11/01/2020 Authors: Olson JJ; Ryken TC
  • Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    J Neurooncol Volume: 150 Page(s): 269 - 359
    11/01/2020 Authors: Farrell C; Shi W; Bodman A; Olson JJ
  • Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults.
    J Neurooncol Volume: 150 Page(s): 165 - 213
    11/01/2020 Authors: Redjal N; Nahed BV; Dietrich J; Kalkanis SN; Olson JJ
  • Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol Volume: 150 Page(s): 121 - 142
    11/01/2020 Authors: Domino JS; Ormond DR; Germano IM; Sami M; Ryken TC; Olson JJ
  • The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol Volume: 150 Page(s): 95 - 120
    11/01/2020 Authors: Lundy P; Domino J; Ryken T; Fouke S; McCracken DJ; Ormond DR; Olson JJ
  • The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    J Neurooncol Volume: 150 Page(s): 215 - 267
    11/01/2020 Authors: Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
  • The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 150 Page(s): 143 - 164
    11/01/2020 Authors: Velzquez Vega JE; Brat DJ; Ryken TC; Olson JJ
  • A phase 0 analysis of ixazomib in patients with glioblastoma.
    Mol Clin Oncol Volume: 13 Page(s): 43
    11/01/2020 Authors: Quillin J; Patel R; Herzberg E; Alton D; Bikzhanova G; Geisler L; Olson J
  • Synthesis, Radiolabeling, and Biological Evaluation of the cis Stereoisomers of 1-Amino-3-Fluoro-4-(fluoro-18F)Cyclopentane-1-Carboxylic Acid as PET Imaging Agents.
    J Med Chem Volume: 63 Page(s): 12008 - 12022
    10/22/2020 Authors: Pickel TC; Voll RJ; Yu W; Wang Z; Nye JA; Bacsa J; Olson JJ; Liebeskind LS; Goodman MM
  • Metastases to the Central Nervous System: A Comprehensive Guide on Current Management and Future Directions.
    Neurosurg Clin N Am Volume: 31 Page(s): xiii - xiv
    10/01/2020 Authors: Nduom EK; Olson JJ
  • Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases.
    Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 157 - 163
    09/01/2020 Authors: Pomeranz Krummel DA; Nasti TH; Izar B; Press RH; Xu M; Lowder L; Kallay L; Rupji M; Rosen H; Su J
  • Therapeutic targeting of the YAP/TAZ pathway in glioblastoma with verteporfin
    Volume: 80
    08/01/2020 Authors: Boyd NH; Vigneswaran K; Lallani S; Oh S-Y; Boucher A; Olson J; Read R
  • Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
    Cancer Volume: 126 Page(s): 3255 - 3264
    07/15/2020 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD
  • A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.
    Clin Cancer Res Volume: 26 Page(s): 2711 - 2724
    06/01/2020 Authors: Lee S-H; Khwaja Rehman F; Tyler KC; Yu B; Zhang Z; Osuka S; Zerrouqi A; Kaluzova M; Hadjipanayis CG; Cummings RD
  • Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
    Sci Rep Volume: 10 Page(s): 7355
    04/30/2020 Authors: Buchwald ZS; Tian S; Rossi M; Smith GH; Switchenko J; Hauenstein JE; Moreno CS; Press RH; Prabhu RS; Zhong J
  • Intracranial thrombosed anastomosing hemangioma: Case report.
    Neuropathology Volume: 40 Page(s): 206 - 210
    04/01/2020 Authors: Bodman A; Goodman A; Olson JJ
  • Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor.
    Oxf Med Case Reports Volume: 2020 Page(s): omaa006
    03/01/2020 Authors: Gurbani SS; Weinberg BD; Salgado E; Voloschin A; Velazquez Vega JE; Olson JJ; Shu H-KG; Shim H
  • Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.
    Int J Cancer Volume: 146 Page(s): 739 - 748
    02/01/2020 Authors: Ostrom QT; Egan KM; Nabors LB; Gerke T; Thompson RC; Olson JJ; LaRocca R; Chowdhary S; Eckel-Passow JE; Armstrong G
  • EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.
    Oncogene Volume: 39 Page(s): 1041 - 1048
    01/01/2020 Authors: Zhang H; Zhu D; Zhang Z; Kaluz S; Yu B; Devi NS; Olson JJ; Van Meir EG
  • Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
    Pract Radiat Oncol Volume: 10 Page(s): 36 - 43
    01/01/2020 Authors: Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B
  • Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.
    Oncogene Volume: 39 Page(s): 1165
    01/01/2020 Authors: Zhang H; Zhu D; Zhang Z; Kaluz S; Yu B; Devi NS; Olson JJ; Van Meir EG
  • Invasive sphenoid sinus aspergillosis mimicking sellar tumor: a report of 4 cases and systematic literature review.
    Chin Neurosurg J Volume: 6 Page(s): 10
    01/01/2020 Authors: Zhang H; Jiang N; Lin X; Wanggou S; Olson JJ; Li X
  • VIGILANT OBSERVATION OF GLIADEL WAFER IMPLANT (VIGILANT) REGISTRY: INTERIM ANALYSIS
    Volume: 21 Page(s): 26 - 26
    11/01/2019 Authors: Lillehei K; Kalkanis S; Liau L; Olson J; Paleologos N; Ryken T; Johnson T; Scullin E
  • RADIATION ENHANCES MELANOMA RESPONSE TO IMMUNOTHERAPY AND SYNERGIZES WITH BENZODIAZEPINES TO PROMOTE ANTI-TUMOR ACTIVITY
    Volume: 21 Page(s): 84 - 84
    11/01/2019 Authors: Krummel DP; Nasti T; Izar B; Xu M; Lowder L; Press R; Kaluzova M; Kallay L; Rupji M; Burnham A
  • REMARKABLE RESPONSE OF A PATIENT WITH SECONDARY GBM TO A HISTONE DEACETYLASE INHIBITOR
    Volume: 21 Page(s): 25 - 25
    11/01/2019 Authors: Shu H-K; Gurbani S; Ramesh K; Weinberg B; Voloschin A; Olson J; Shim H
  • SPECTROSCOPIC MRI TO GUIDE BIOPSY OF LOWER GRADE GLIOMAS
    Volume: 21 Page(s): 246 - 246
    11/01/2019 Authors: Olson J; Weinberg B; Gurbani S; Ramesh K; Schreibmann E; Shu H-K; Shim H
  • Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
    Neurosurgery Volume: 85 Page(s): 632 - 641
    11/01/2019 Authors: Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu H-KG; Curran WJ
  • Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas COMMENT
    NEUROSURGERY Volume: 85 Page(s): E648 - E649
    10/01/2019 Authors: Mohammadi AM; Ormond DR; Bodman AB; Olson JJ
  • Presentation of treatment effect in glioblastoma after dose-escalation radiation therapy.
    Oxf Med Case Reports Volume: 2019 Page(s): omz085
    09/01/2019 Authors: Cicka D; Ford CL; Templin E; Pitts Z; Gurbani S; Eaton B; Lowder L; Olson J; Weinberg BD; Shim H
  • Evaluating the Landscape of Clinical Research in Neurosurgery COMMENT
    NEUROSURGERY Volume: 85 Page(s): E492 - E493
    09/01/2019 Authors: Bodman AB; Olson JJ
  • The Immune Landscape of Cancer.
    Immunity Volume: 51 Page(s): 411 - 412
    08/20/2019 Authors: Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang T-H; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA
  • Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma.
    Sci Rep Volume: 9 Page(s): 10861
    07/26/2019 Authors: Creed JH; Peeri NC; Anic GM; Thompson RC; Olson JJ; LaRocca RV; Chowdhary SA; Brockman JD; Gerke TA; Nabors LB
  • Identification of the GABAA receptor in melanoma brain metastases patient tumors and demonstration that it is a viable drug target using benzodiazepine-derivatives
    Volume: 79
    07/01/2019 Authors: Kaluzova M; Nasti T; Chen H-R; Lowder L; Press R; Rosen H; Rupji M; Kallay L; Patel R; Burnham A
  • Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis.
    J Neurooncol Volume: 143 Page(s): 381 - 392
    07/01/2019 Authors: Lowder L; Hauenstein J; Woods A; Chen H-R; Rupji M; Kowalski J; Olson JJ; Saxe D; Schniederjan M; Neill S
  • Institutional Implementation of a Structured Reporting System: Our Experience with the Brain Tumor Reporting and Data System.
    Acad Radiol Volume: 26 Page(s): 974 - 980
    07/01/2019 Authors: Gore A; Hoch MJ; Shu H-KG; Olson JJ; Voloschin AD; Weinberg BD
  • Low-Grade Diffuse Glioma In The Elderly: A Novel Tumor Hiding In Plain Sight?
    Volume: 78 Page(s): 531 - 531
    06/01/2019 Authors: Goodman A; Neill S; Lowder L; Olson J; Vega JV; Schniederjan M
  • Cerebellar Liponeurocytoma: A Case Report with Cytogenetic Analysis
    Volume: 78 Page(s): 537 - 538
    06/01/2019 Authors: Morales-Vargas B; Lowder L; Goodman A; Neill S; Hunter S; Olson J; Schniederjan M
  • The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma.
    Volume: 37
    05/20/2019 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan T; Behera M; Sengupta S; Voloschin AD
  • Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    J Neurosurg Volume: 130 Page(s): 797 - 803
    03/01/2019 Authors: Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E152 - E155
    03/01/2019 Authors: Nahed BV; Alvarez-Breckenridge C; Brastianos PK; Shih H; Sloan A; Ammirati M; Kuo JS; Ryken TC; Kalkanis SN; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Prophylactic Anticonvulsants in the Treatment of Adults with Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E195 - E197
    03/01/2019 Authors: Chen CC; Rennert RC; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Chemotherapy in the Management of Adults With Newly Diagnosed Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E175 - E177
    03/01/2019 Authors: Sherman JH; Lo SS; Harrod T; Hdeib A; Li Y; Ryken T; Olson JJ
  • Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI.
    Tomography Volume: 5 Page(s): 53 - 60
    03/01/2019 Authors: Gurbani SS; Yoon Y; Weinberg BD; Salgado E; Press RH; Cordova JS; Ramesh KK; Liang Z; Velazquez Vega J; Voloschin A
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E168 - E170
    03/01/2019 Authors: Graber JJ; Cobbs CS; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Emerging and Investigational Therapties for the Treatment of Adults With Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E201 - E203
    03/01/2019 Authors: Elder JB; Nahed BV; Linskey ME; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E159 - E162
    03/01/2019 Authors: Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Steroids in the Treatment of Adults With Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E189 - E191
    03/01/2019 Authors: Ryken TC; Kuo JS; Prabhu RS; Sherman JH; Kalkanis SN; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Treatment Options for Adults With Multiple Metastatic Brain Tumors.
    Neurosurgery Volume: 84 Page(s): E180 - E182
    03/01/2019 Authors: Ammirati M; Nahed BV; Andrews D; Chen CC; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Treatment of Adults With Metastatic Brain Tumors: Executive Summary.
    Neurosurgery Volume: 84 Page(s): 550 - 552
    03/01/2019 Authors: Olson JJ; Kalkanis SN; Ryken TC
  • Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression.
    Neuro Oncol Volume: 21 Page(s): 234 - 241
    02/14/2019 Authors: Huang RY; Unadkat P; Bi WL; George E; Preusser M; McCracken JD; Keen JR; Read WL; Olson JJ; Seystahl K
  • The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma.
    Oxf Med Case Reports Volume: 2018 Page(s): omy095
    12/01/2018 Authors: Doyle SP; Gurbani SS; Ross AS; Rosen H; Barrett CD; Olson JJ; Shim H; Shu H-K; Sengupta S
  • CLINICAL AND DOSIMETRIC FACTORS RELATED TO RADIATION NECROSIS AFTER FIVE FRACTION RADIOSURGERY FOR RESECTED BRAIN METASTASES
    Volume: 20 Page(s): 54 - 54
    11/01/2018 Authors: Buchwald Z; Jhaveri J; Schreibmann E; Switchenko J; Prabhu R; Chowdhary M; Abugideiri M; Eaton B; Olson J; Shu H-K
  • LARGE SCALE TRANSCRIPTOMIC ANALYSIS OF MELANOMA BRAIN METASTASES
    Volume: 20 Page(s): 68 - 68
    11/01/2018 Authors: Kowalski J; Krummel DP; Rupji M; Dwivedi B; Keskin H; Kallay L; Xu M; Ross A; Press R; Rosen H
  • COPY NUMBER (CN)/SINGLE NUCLEOTIDE POLYMORPHISM (SNP) MICROARRAY ANALYSIS OF THE EGFR LOCUS IN GLIOSARCOMA
    Volume: 20 Page(s): 160 - 160
    11/01/2018 Authors: Lowder L; Woods A; Neill S; Hauenstein J; Debra S; Weinberg B; Olson J; Shu H-K; Eaton B; Sengupta S
  • EPIGENETIC LOSS OF BAI1 EXPRESSION IN CEREBELLAR GRANULE NEURON PRECURSORS INACTIVATES THE p53 TUMOR SUPPRESSOR AND FACILITATES MEDULLOBLASTOMA FORMATION IN THE CEREBELLUM
    Volume: 20 Page(s): 209 - 209
    11/01/2018 Authors: Zhu D; Osuka S; Zhang Z; Reichert Z; Kanemura Y; Nishikawa R; Nelson WG; Olson JJ; Van Meir EG
  • SMALL MOLECULE EPIGENETIC TARGETING OF METHYL-CPG BINDING PROTEIN 2 (MBD2) FOR MEDULLOBLASTOMA THERAPY
    Volume: 20 Page(s): 280 - 280
    11/01/2018 Authors: Van Meir E; Olson J; Zhu D; Osuka S; Zhang Z
  • The use of Hypofractionated Radiosurgery for the Treatment of Intracranial Lesions Unsuitable for Single-Fraction Radiosurgery.
    Neurosurgery Volume: 83 Page(s): 850 - 857
    11/01/2018 Authors: Zhong J; Press RH; Olson JJ; Oyesiku NM; Shu H-KG; Eaton BR
  • Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer.
    Cell Rep Volume: 25 Page(s): 1304 - 1317.e5
    10/30/2018 Authors: Wang Y; Xu X; Maglic D; Dill MT; Mojumdar K; Ng PK-S; Jeong KJ; Tsang YH; Moreno D; Bhavana VH
  • A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF- Superfamily.
    Cell Syst Volume: 7 Page(s): 422 - 437.e7
    10/24/2018 Authors: Korkut A; Zaidi S; Kanchi RS; Rao S; Gough NR; Schultz A; Li X; Lorenzi PL; Berger AC; Robertson G
  • CHARACTERIZING THE OVER-EXPRESSION OF YKI/YAP/TAZ TRANSCRIPTION FACTORS IN GLIOMAGENESIS AND RESULTS OF A PHASE 0 CLINICAL TRIAL FOR A PROPOSED NOVEL TREATMENT OF GLIOBLASTOMAS
    Volume: 20 Page(s): 218 - 218
    09/01/2018 Authors: Vigneswaran K; Oh S; Lallani S; Read R; Olson J
  • Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery.
    J Neurooncol Volume: 139 Page(s): 689 - 697
    09/01/2018 Authors: Chowdhary M; Switchenko JM; Press RH; Jhaveri J; Buchwald ZS; Blumenfeld PA; Marwaha G; Diaz A; Wang D; Abrams RA
  • Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
    Cancer Cell Volume: 34 Page(s): 211 - 224.e6
    08/13/2018 Authors: Kahles A; Lehmann K-V; Toussaint NC; Hser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; Cancer Genome Atlas Research Network
  • Comprehensive Characterization of Cancer Driver Genes and Mutations.
    Cell Volume: 174 Page(s): 1034 - 1035
    08/09/2018 Authors: Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B
  • Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma.
    Cancer Epidemiol Volume: 55 Page(s): 45 - 51
    08/01/2018 Authors: Peeri NC; Creed JH; Anic GM; Thompson RC; Olson JJ; LaRocca RV; Chowdhary SA; Brockman JD; Gerke TA; Nabors LB
  • [18F]Fluciclovine PET discrimination between high- and low-grade gliomas.
    EJNMMI Res Volume: 8 Page(s): 67
    07/25/2018 Authors: Parent EE; Benayoun M; Ibeanu I; Olson JJ; Hadjipanayis CG; Brat DJ; Adhikarla V; Nye J; Schuster DM; Goodman MM
  • Evaluating glioma risk associated with extent of European admixture in African-Americans and Latinos
    Volume: 78
    07/01/2018 Authors: Ostrom QT; Egan KM; Nabors LB; Gerke T; Thompson RC; Olson JJ; LaRocca R; Chowdhary S; Eckel-Passow JE; Armstrong G
  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Cell Rep Volume: 23 Page(s): 3698
    06/19/2018 Authors: Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R
  • BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.
    Cancer Cell Volume: 33 Page(s): 1004 - 1016.e5
    06/11/2018 Authors: Zhu D; Osuka S; Zhang Z; Reichert ZR; Yang L; Kanemura Y; Jiang Y; You S; Zhang H; Devi NS
  • Correlation of genomic copy number variation with survival outcomes in high-grade glioma patients
    Volume: 36
    05/20/2018 Authors: Buchwald Z; Rossi MR; Smith G; Switchenko JM; Hauenstein J; Zhong J; Press RH; Tian S; Saxe D; Neill S
  • Handedness and the risk of glioma.
    J Neurooncol Volume: 137 Page(s): 639 - 644
    05/01/2018 Authors: Miller B; Peeri NC; Nabors LB; Creed JH; Thompson ZJ; Rozmeski CM; LaRocca RV; Chowdhary S; Olson JJ; Thompson RC
  • Management-Based Structured Reporting of Posttreatment Glioma Response With the BrainTumor Reporting and Data System.
    J Am Coll Radiol Volume: 15 Page(s): 767 - 771
    05/01/2018 Authors: Weinberg BD; Gore A; Shu H-KG; Olson JJ; Duszak R; Voloschin AD; Hoch MJ
  • Fluciclovine PET Imaging of Intracranial Metastases
    Volume: 59
    05/01/2018 Authors: Patel D; Nye J; Schuster D; Olson J; Goodman M; Parent E
  • The Immune Landscape of Cancer.
    Immunity Volume: 48 Page(s): 812 - 830.e14
    04/17/2018 Authors: Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang T-H; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA
  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
    Cancer Cell Volume: 33 Page(s): 690 - 705.e9
    04/09/2018 Authors: Berger AC; Korkut A; Kanchi RS; Hegde AM; Lenoir W; Liu W; Liu Y; Fan H; Shen H; Ravikumar V
  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy.
    Cancer Cell Volume: 33 Page(s): 676 - 689.e3
    04/09/2018 Authors: Taylor AM; Shih J; Ha G; Gao GF; Zhang X; Berger AC; Schumacher SE; Wang C; Hu H; Liu J
  • Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
    Cancer Cell Volume: 33 Page(s): 721 - 735.e8
    04/09/2018 Authors: Liu Y; Sethi NS; Hinoue T; Schneider BG; Cherniack AD; Sanchez-Vega F; Seoane JA; Farshidfar F; Bowlby R; Islam M
  • lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.
    Cancer Cell Volume: 33 Page(s): 706 - 720.e9
    04/09/2018 Authors: Wang Z; Yang B; Zhang M; Guo W; Wu Z; Wang Y; Jia L; Li S; Cancer Genome Atlas Research Network; Xie W
  • Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
    Cell Volume: 173 Page(s): 305 - 320.e10
    04/05/2018 Authors: Ding L; Bailey MH; Porta-Pardo E; Thorsson V; Colaprico A; Bertrand D; Gibbs DL; Weerasinghe A; Huang K-L; Tokheim C
  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
    Cell Volume: 173 Page(s): 291 - 304.e6
    04/05/2018 Authors: Hoadley KA; Yau C; Hinoue T; Wolf DM; Lazar AJ; Drill E; Shen R; Taylor AM; Cherniack AD; Thorsson V
  • A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.
    Cell Volume: 173 Page(s): 386 - 399.e12
    04/05/2018 Authors: Chen H; Li C; Peng X; Zhou Z; Weinstein JN; Cancer Genome Atlas Research Network; Liang H
  • Oncogenic Signaling Pathways in The Cancer Genome Atlas.
    Cell Volume: 173 Page(s): 321 - 337.e10
    04/05/2018 Authors: Sanchez-Vega F; Mina M; Armenia J; Chatila WK; Luna A; La KC; Dimitriadoy S; Liu DL; Kantheti HS; Saghafinia S
  • An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
    Cell Volume: 173 Page(s): 400 - 416.e11
    04/05/2018 Authors: Liu J; Lichtenberg T; Hoadley KA; Poisson LM; Lazar AJ; Cherniack AD; Kovatich AJ; Benz CC; Levine DA; Lee AV
  • Comprehensive Characterization of Cancer Driver Genes and Mutations.
    Cell Volume: 173 Page(s): 371 - 385.e18
    04/05/2018 Authors: Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B
  • Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
    Cell Rep Volume: 23 Page(s): 172 - 180.e3
    04/03/2018 Authors: Way GP; Sanchez-Vega F; La K; Armenia J; Chatila WK; Luna A; Sander C; Cherniack AD; Mina M; Ciriello G
  • Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
    Cell Rep Volume: 23 Page(s): 213 - 226.e3
    04/03/2018 Authors: Ge Z; Leighton JS; Wang Y; Peng X; Chen Z; Chen H; Sun Y; Yao F; Li J; Zhang H
  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
    Cell Rep Volume: 23 Page(s): 194 - 212.e6
    04/03/2018 Authors: Campbell JD; Yau C; Bowlby R; Liu Y; Brennan K; Fan H; Taylor AM; Wang C; Walter V; Akbani R
  • Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
    Cell Rep Volume: 23 Page(s): 255 - 269.e4
    04/03/2018 Authors: Peng X; Chen Z; Farshidfar F; Xu X; Lorenzi PL; Wang Y; Cheng F; Tan L; Mojumdar K; Du D
  • Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
    Cell Rep Volume: 23 Page(s): 227 - 238.e3
    04/03/2018 Authors: Gao Q; Liang W-W; Foltz SM; Mutharasu G; Jayasinghe RG; Cao S; Liao W-W; Reynolds SM; Wyczalkowski MA; Yao L
  • Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.
    Cell Rep Volume: 23 Page(s): 297 - 312.e12
    04/03/2018 Authors: Chiu H-S; Somvanshi S; Patel E; Chen T-W; Singh VP; Zorman B; Patil SL; Pan Y; Chatterjee SS; Cancer Genome Atlas Research Network
  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
    Cell Rep Volume: 23 Page(s): 313 - 326.e5
    04/03/2018 Authors: Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R
  • Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
    Cell Rep Volume: 23 Page(s): 282 - 296.e4
    04/03/2018 Authors: Seiler M; Peng S; Agrawal AA; Palacino J; Teng T; Zhu P; Smith PG; Cancer Genome Atlas Research Network; Buonamici S; Yu L
  • Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
    Cell Rep Volume: 23 Page(s): 270 - 281.e3
    04/03/2018 Authors: Jayasinghe RG; Cao S; Gao Q; Wendl MC; Vo NS; Reynolds SM; Zhao Y; Climente-Gonzlez H; Chai S; Wang F
  • Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images.
    Cell Rep Volume: 23 Page(s): 181 - 193.e7
    04/03/2018 Authors: Saltz J; Gupta R; Hou L; Kurc T; Singh P; Nguyen V; Samaras D; Shroyer KR; Zhao T; Batiste R
  • Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
    Cell Rep Volume: 23 Page(s): 239 - 254.e6
    04/03/2018 Authors: Knijnenburg TA; Wang L; Zimmermann MT; Chambwe N; Gao GF; Cherniack AD; Fan H; Shen H; Way GP; Greene CS
  • Neutrophil-to-lymphocyte ratio as a predictor of overall survival in brain metastases following SRS
    Volume: 127 Page(s): S370 - S371
    04/01/2018 Authors: Chowdhary M; Switchenko J; Abrams R; Wang D; Marwaha G; Blumenfeld P; Press R; Jhaveri J; Olson J; Shu HK
  • Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry.
    CNS Oncol Volume: 7 Page(s): CNS08
    04/01/2018 Authors: Lillehei KO; Kalkanis SN; Liau LM; Mydland DE; Olson J; Paleologos NA; Ryken T; Johnson T; Scullin E
  • Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
    Cell Syst Volume: 6 Page(s): 271 - 281.e7
    03/28/2018 Authors: Ellrott K; Bailey MH; Saksena G; Covington KR; Kandoth C; Stewart C; Hess J; Ma S; Chiotti KE; McLellan M
  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
    Cell Syst Volume: 6 Page(s): 282 - 300.e2
    03/28/2018 Authors: Schaub FX; Dhankani V; Berger AC; Trivedi M; Richardson AB; Shaw R; Zhao W; Zhang X; Ventura A; Liu Y
  • Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
    Cancer Volume: 124 Page(s): 1169 - 1178
    03/15/2018 Authors: Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu H-KG; Crocker IR
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Surgical Resection for the Treatment of Patients With Vestibular Schwannomas.
    Neurosurgery Volume: 82 Page(s): E40 - E43
    02/01/2018 Authors: Hadjipanayis CG; Carlson ML; Link MJ; Rayan TA; Parish J; Atkins T; Asher AL; Dunn IF; Corrales CE; Van Gompel JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Treatment of Adults With Vestibular Schwannomas: Executive Summary.
    Neurosurgery Volume: 82 Page(s): 129 - 134
    02/01/2018 Authors: Olson JJ; Kalkanis SN; Ryken TC
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas.
    Neurosurgery Volume: 82 Page(s): E52 - E54
    02/01/2018 Authors: Van Gompel JJ; Agazzi S; Carlson ML; Adewumi DA; Hadjipanayis CG; Uhm JH; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas.
    Neurosurgery Volume: 82 Page(s): E49 - E51
    02/01/2018 Authors: Germano IM; Sheehan J; Parish J; Atkins T; Asher A; Hadjipanayis CG; Burri SH; Green S; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
    Neurosurgery Volume: 82 Page(s): E32 - E34
    02/01/2018 Authors: Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Pathological Methods and Prognostic Factors in Vestibular Schwannomas.
    Neurosurgery Volume: 82 Page(s): E47 - E48
    02/01/2018 Authors: Sughrue ME; Fung K-M; Van Gompel JJ; Peterson JEG; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Intraoperative Cranial Nerve Monitoring in Vestibular Schwannoma Surgery.
    Neurosurgery Volume: 82 Page(s): E44 - E46
    02/01/2018 Authors: Vivas EX; Carlson ML; Neff BA; Shepard NT; McCracken DJ; Sweeney AD; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Otologic and Audiologic Screening for Patients With Vestibular Schwannomas.
    Neurosurgery Volume: 82 Page(s): E29 - E31
    02/01/2018 Authors: Sweeney AD; Carlson ML; Shepard NT; McCracken DJ; Vivas EX; Neff BA; Olson JJ
  • Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Neurosurgery Volume: 82 Page(s): E35 - E39
    02/01/2018 Authors: Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
  • Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
    NPJ Precis Oncol Volume: 2 Page(s): 24
    01/01/2018 Authors: Halani SH; Yousefi S; Velazquez Vega J; Rossi MR; Zhao Z; Amrollahi F; Holder CA; Baxter-Stoltzfus A; Eschbacher J; Griffith B
  • Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
    Front Oncol Volume: 8 Page(s): 440
    01/01/2018 Authors: Jhaveri J; Cheng E; Tian S; Buchwald Z; Chowdhary M; Liu Y; Gillespie TW; Olson JJ; Diaz AZ; Voloschin A
  • Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma.
    J Neurooncol Volume: 136 Page(s): 327 - 333
    01/01/2018 Authors: Harland TA; Freeman JL; Davern M; McCracken DJ; Celano EC; Lillehei K; Olson JJ; Ormond DR
  • Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.
    J Neurooncol Volume: 136 Page(s): 289 - 298
    01/01/2018 Authors: Chowdhary M; Okwan-Duodu D; Switchenko JM; Press RH; Jhaveri J; Buchwald ZS; Zhong J; Chapman BV; Bindra RS; Contessa JN
  • ASSESSING TREATMENT RESPONSE OF GLIOBLASTOMA TO AN HDAC INHIBITOR, BELINOSTAT (PXD101)
    Volume: 19 Page(s): 148 - 148
    11/01/2017 Authors: Gurbani S; Sengupta S; Voloschin A; Liang Z; Yoon Y; Vega JEV; Holder CA; Olson JJ; Shu H-K; Shim H
  • PATIENT OUTCOMES AND FACTORS ASSOCIATED WITH RECEIPT OF PROTON RADIATION THERAPY FOR ADULTS WITH PRIMARY GLIOMAS: ANALYSIS OF THE NATIONAL CANCER DATA BASE
    Volume: 19 Page(s): 223 - 224
    11/01/2017 Authors: Jhaveri J; Cheng E; Liu Y; Ferris M; Chowdhary M; Morgan T; Gillespie T; Olson JJ; Voloschin A; Eaton B
  • MARKERS AND MECHANISMS OF DISEASE PROGRESSION IN IDH-MUTANT ASTROCYTOMAS
    NEURO-ONCOLOGY Volume: 19 Page(s): 178 - 178
    11/01/2017 Authors: Halani SH; Yousefi S; Vega JEV; Baxter-Stoltzfus A; Olson JJ; Cooper L; Brat D
  • CHARACTERIZING THE OVER-EXPRESSION OF Yki/YAP/TAZ TRANSCRIPTION FACTORS IN GLIOMAGENESIS AND A PROPOSED NOVEL TREATMENT OF GLIOBLASTOMAS
    Volume: 19 Page(s): 56 - 56
    11/01/2017 Authors: Vigneswaran K; Oh S-Y; Zhang Z; Olson JJ; Read R
  • HEMORRHAGIC BRAIN METASTASES UNDERGOING SURGICAL RESECTION ARE ASSOCIATED WITH INCREASED RISK OF LEPTOMENINGEAL DISSEMINATION
    Volume: 19 Page(s): 47 - 47
    11/01/2017 Authors: Press R; Zhang C; Chowdhary M; Xu K; Prabhu R; Ferris M; Olson JJ; Eaton BR; Shu H-K; Curran W
  • EVALUATING GLIOMA RISK ASSOCIATED WITH EXTENT OF EUROPEAN ADMIXTURE IN AFRICAN-AMERICANS AND LATINOS
    Volume: 19 Page(s): 102 - 103
    11/01/2017 Authors: Ostrom Q; Egan K; Nabors B; Amos C; Armstrong G; Bernstein J; Chowdhary S; Claus E; Eckel-Passow J; Gerke T
  • SPECTROSCOPIC MRI PREDICTS RECURRENCE PATTERNS IN GLIOBLASTOMA
    Volume: 19 Page(s): 219 - 219
    11/01/2017 Authors: Gurbani S; Kleinberg L; Zhong J; Holder CA; Olson JJ; Mellon E; Maudsley A; Shu H-K; Shim H
  • Post-treatment Neutrophil-to-Lymphocyte Ratio as a Predictor of Overall Survival in Melanoma Brain Metastases treated with Stereotactic Radiosurgery
    Volume: 99 Page(s): S169 - S169
    10/01/2017 Authors: Chowdhary M; Switchenko J; Marwaha G; Abrams RA; Jhaveri J; Olson JJ; Shu HKG; Curran WJ; Khan MK; Patel K
  • Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma.
    Cancer Causes Control Volume: 28 Page(s): 717 - 718
    07/01/2017 Authors: Little RB; Burt Nabors L; Olson JJ; Thompson ZJ; Rozmeski CM; LaRocca RV; Forsyth PA; Thompson RC; Oster RA; Chowdhary SA
  • Older age at the completion of linear growth is associated with an increased risk of adult glioma.
    Cancer Causes Control Volume: 28 Page(s): 709 - 716
    07/01/2017 Authors: Little RB; Nabors LB; Olson JJ; Thompson ZJ; Rozmeski CM; LaRocca RV; Forsyth PA; Thompson RC; Oster RA; Chowdhary SA
  • The Role of NOTCH1 and PI3K Pathways In The Progression of Oligodendrogliomas
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 76 Page(s): 515 - 515
    06/01/2017 Authors: Vega JV; Halani S; Yousefi S; Amrol-Lahi F; Holder C; Poisson L; Griffith B; Eschbacher J; Nalisnik M; Olson J
  • YAP/TAZ FUNCTION IN PEDIATRIC GLIOBLASTOMAS
    Volume: 19 Page(s): 50 - 51
    06/01/2017 Authors: Read R; Oh S-Y; Schniederjan M; Kenney A; Becher O; Olson J
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Post-Operative Stereotactic Radiosurgery Alone to Resected Brain Metastases
    Volume: 44 Page(s): 2973 - 2973
    06/01/2017 Authors: Jhaveri J; Zhang X; Chowdhary M; Switchenko J; Press R; Cassidy R; Morgan T; Roper J; Dhabaan A; Elder E
  • Degree of Vascular Encasement in Sphenoid Wing Meningiomas Predicts Postoperative Ischemic Complications.
    Neurosurgery Volume: 80 Page(s): 957 - 966
    06/01/2017 Authors: McCracken DJ; Higginbotham RA; Boulter JH; Liu Y; Wells JA; Halani SH; Saindane AM; Oyesiku NM; Barrow DL; Olson JJ
  • Is less more? Comparing chemotherapy alone to chemotherapy and radiation for high risk, grade II glioma-An analysis of the National Cancer Data Base.
    Volume: 35
    05/20/2017 Authors: Jhaveri J; Liu Y; Gillespie TW; Chowdhary M; Buchwald Z; Olson JJ; Voloschin AD; Shu H-KG; Crocker IR; Curran WJ
  • Markers of Progression in Oligodendroglioma
    MODERN PATHOLOGY Volume: 30 Page(s): 438A - 438A
    02/01/2017 Authors: Vega JEV; Halani SH; Yousefi S; Amrollahi F; Holder CA; Poisson LM; Griffith B; Eschbacher J; Nalisnik M; Olson JJ
  • Markers of Progression in Oligodendroglioma
    LABORATORY INVESTIGATION Volume: 97 Page(s): 438A - 438A
    02/01/2017 Authors: Velazquez Vega JE; Halani SH; Yousefi S; Amrollahi F; Holder CA; Poisson LM; Griffith B; Eschbacher J; Nalisnik M; Olson JJ
  • Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
    J Neurooncol Volume: 131 Page(s): 611 - 618
    02/01/2017 Authors: Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ
  • Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
    Pract Radiat Oncol Volume: 7 Page(s): e419 - e425
    01/01/2017 Authors: Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu H-KG; Crocker IR
  • Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase.
    Clin Cancer Res Volume: 22 Page(s): 6256 - 6265
    12/15/2016 Authors: Kalinina J; Ahn J; Devi NS; Wang L; Li Y; Olson JJ; Glantz M; Smith T; Kim EL; Giese A
  • AN INVESTIGATION OF BRAIN-TUMOR RELATED EPILEPSY IN THE GliomaSE CONSORTIUM
    Volume: 18 Page(s): 157 - 158
    11/01/2016 Authors: Warren P; Nabors B; Peeri N; Thompson Z; Thompson R; Chowdhary S; Olson JJ; LaRocca R; Rozmeski C; Forsyth P
  • TARGETING MEDULLOBLASTOMA WITH BENZODIAZAPINES DELIVERED USING TUNABLE BIODEGRADABLE HYDROGELS
    Volume: 18 Page(s): 156 - 156
    11/01/2016 Authors: Kallay L; Krummel DP; Methuku KR; Zhang Z; Cook J; Olson J; Brat D; MacDonald T; Sydlik S; Sengupta S
  • MET FUSION, AMPLIFICATION, AND/OR OVEREXPRESSION DEFINES DIFFUSELY INVASIVE TUMOR CELLS IN PEDIATRIC AND ADULT GLIOBLASTOMA
    Volume: 18 Page(s): 46 - 46
    11/01/2016 Authors: Vigneswaran K; Read R; Olson JJ; MacDonald T; Neill S; Rossi M
  • GENETIC ALTERATIONS ASSOCIATED WITH RADIOGRAPHIC FEATURES OF PROGRESSION OF IDH-MUTANT/1p19q CO-DELETED GLIOMAS
    NEURO-ONCOLOGY Volume: 18 Page(s): 73 - 73
    11/01/2016 Authors: Halani SH; Holder CA; Griffith B; Nalisnik M; Eschbacher J; Poisson L; Vega JEV; Olson JJ; Cooper L; Brat D
  • YAP FUNCTION IN PEDIATRIC GLIOBLASTOMAS
    Volume: 18 Page(s): 155 - 155
    11/01/2016 Authors: Read R; Kenney A; Schniederjan M; Olson JJ
  • Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma.
    J Neurooncol Volume: 130 Page(s): 193 - 201
    10/01/2016 Authors: McCracken DJ; Celano EC; Voloschin AD; Read WL; Olson JJ
  • Genomic Copy Number Complexity Correlates With Overall Survival in Glioblastoma Patients.
    Volume: 96 Page(s): S92 - S93
    10/01/2016 Authors: Buchwald ZS; Rossi M; Smith G; Abugideiri M; Hauenstein JE; Saxe DF; Neill SG; Ali AN; Brat DJ; Olson JJ
  • Genomic Copy Number Complexity Correlates With Overall Survival in Glioblastoma Patients
    Volume: 96 Page(s): S92 - S93
    10/01/2016 Authors: Buchwald ZS; Rossi M; Smith G; Abugideiri M; Hauenstein JE; Saxe DF; Neill SG; Ali AN; Brat DJ; Olson JJ
  • Comparing Preoperative Stereotactic Radiosurgery (SRS) to Postoperative Whole-Brain Radiation Therapy (WBRT) for Resectable Brain Metastases: A Multi-Institutional Analysis.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E85 - E86
    10/01/2016 Authors: Patel K; Burri SH; Symanowski J; Boselli D; Sumrall A; Press RH; Fraser RW; Zhong J; Olson JJ; Curran WJ
  • Genomic Copy Number Complexity Correlates With Overall Survival in Glioblastoma Patients
    Volume: 96 Page(s): S92 - S93
    10/01/2016 Authors: Buchwald ZS; Rossi M; Smith G; Abugideiri M; Hauenstein JE; Saxe DF; Neill SG; Ali AN; Brat DJ; Olson JJ
  • The role of glutamate transport and SLC7A11 expression in tumor-associate seizures and survival in patients with malignant gliomas.
    Ann Transl Med Volume: 4 Page(s): S18
    10/01/2016 Authors: Keen JR; Swanger SA; Traynelis SF; Olson JJ
  • Analgesic use and the risk of primary adult brain tumor.
    Eur J Epidemiol Volume: 31 Page(s): 917 - 925
    09/01/2016 Authors: Egan KM; Nabors LB; Thompson ZJ; Rozmeski CM; Anic GA; Olson JJ; LaRocca RV; Chowdhary SA; Forsyth PA; Thompson RC
  • Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
    Neurosurgery Volume: 79 Page(s): 279 - 285
    08/01/2016 Authors: Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH
  • Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.
    Neuro Oncol Volume: 18 Page(s): 1180 - 1189
    08/01/2016 Authors: Cordova JS; Shu H-KG; Liang Z; Gurbani SS; Cooper LAD; Holder CA; Olson JJ; Kairdolf B; Schreibmann E; Neill SG
  • Update on the evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: the role of initial chemotherapy.
    J Neurooncol Volume: 128 Page(s): 487 - 489
    07/01/2016 Authors: Ziu M; Olson JJ
  • BAI1 IS A TUMOR SUPPRESSOR IN MEDULLOBLASTOMA
    Volume: 18 Page(s): 98 - 98
    06/01/2016 Authors: Zhu D; Reichert Z; Nelson W; Olson J; Van Meir E
  • Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
    Mol Imaging Biol Volume: 18 Page(s): 454 - 462
    06/01/2016 Authors: Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu H-KG; Shim H; Hadjipanayis CG
  • A systematic pipeline for the objective comparison of whole-brain spectroscopic MRI with histology in biopsy specimens from grade III glioma.
    Tomography Volume: 2 Page(s): 106 - 116
    06/01/2016 Authors: Cordova JS; Gurbani SS; Olson JJ; Liang Z; Cooper LAD; Shu H-KG; Schreibmann E; Neill SG; Hadjipanayis CG; Holder CA
  • Adult-onset Leukoencephalopathy with Cerebral Calcifications and Cysts (Labrune Syndrome): A Case With Novel Copy Number Abnormalities
    Volume: 75 Page(s): 613 - 613
    06/01/2016 Authors: Vega JV; Neill S; Schniederjan M; Hunter S; Brat D; Saxe D; Rossi M; Holder C; Olson J
  • Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.
    Lancet Oncol Volume: 17 Page(s): 484 - 495
    04/01/2016 Authors: Thompson EM; Hielscher T; Bouffet E; Remke M; Luu B; Gururangan S; McLendon RE; Bigner DD; Lipp ES; Perreault S
  • Divergent clonal selection dominates medulloblastoma at recurrence.
    Nature Volume: 529 Page(s): 351 - 357
    01/21/2016 Authors: Morrissy AS; Garzia L; Shih DJH; Zuyderduyn S; Huang X; Skowron P; Remke M; Cavalli FMG; Ramaswamy V; Lindsay PE
  • Evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: introduction and methods.
    J Neurooncol Volume: 125 Page(s): 449 - 456
    12/01/2015 Authors: Olson JJ; Kalkanis SN; Ryken TC
  • Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 125 Page(s): 609 - 630
    12/01/2015 Authors: Nahed BV; Redjal N; Brat DJ; Chi AS; Oh K; Batchelor TT; Ryken TC; Kalkanis SN; Olson JJ
  • The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 125 Page(s): 551 - 583
    12/01/2015 Authors: Ryken TC; Parney I; Buatti J; Kalkanis SN; Olson JJ
  • The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 125 Page(s): 503 - 530
    12/01/2015 Authors: Aghi MK; Nahed BV; Sloan AE; Ryken TC; Kalkanis SN; Olson JJ
  • The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 125 Page(s): 531 - 549
    12/01/2015 Authors: Cahill DP; Sloan AE; Nahed BV; Aldape KD; Louis DN; Ryken TC; Kalkanis SN; Olson JJ
  • The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 125 Page(s): 457 - 479
    12/01/2015 Authors: Fouke SJ; Benzinger T; Gibson D; Ryken TC; Kalkanis SN; Olson JJ
  • The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma : A systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 125 Page(s): 585 - 607
    12/01/2015 Authors: Ziu M; Kalkanis SN; Gilbert M; Ryken TC; Olson JJ
  • The role of emerging therapy in the management of patients with diffuse low grade glioma.
    J Neurooncol Volume: 125 Page(s): 631 - 635
    12/01/2015 Authors: Sloan AE; Okada H; Ryken TC; Kalkanis SN; Olson JJ
  • The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 125 Page(s): 481 - 501
    12/01/2015 Authors: Ragel BT; Ryken TC; Kalkanis SN; Ziu M; Cahill D; Olson JJ
  • Impact of Angiotensin Blockade on Symptomatic Radiation Necrosis Following Stereotactic Radiosurgery
    Volume: 93 Page(s): E360 - E360
    11/01/2015 Authors: Okwan-Duodu D; Patel K; Zhong J; Prabhu RS; Eaton BR; Olson J; Shu HKG; Curran WJ; Crocker IR
  • Comparing Preoperative Stereotactic Radiosurgery (SRS) to Postoperative SRS for Resectable Brain Metastases
    Volume: 93 Page(s): S38 - S39
    11/01/2015 Authors: Patel K; Asher A; Burri SH; Fraser RW; Kandula S; Press RH; Chen Z; Zhang C; Hadjipanayis CG; Olson J
  • Volumetric MR Spectroscopic Imaging Can Identify Infiltrating Glioblastoma for Targeting Radiation Therapy
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 93 Page(s): S168 - S169
    11/01/2015 Authors: Shu HKG; Cordova JS; Hadjipanayis CG; Kandula S; Liang Z; Cooper LAD; Holder CA; Schreibmann E; Olson JJ; Shim H
  • A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
    Volume: 17 Page(s): 1386 - 1392
    10/01/2015 Authors: Gerstner ER; Ye X; Duda DG; Levine MA; Mikkelsen T; Kaley TJ; Olson JJ; Nabors BL; Ahluwalia MS; Wen PY
  • Outcome of Adult Brain Tumor Consortium (ABTC) prospective dose-finding trials of I-125 balloon brachytherapy in high-grade gliomas: challenges in clinical trial design and technology development when MRI treatment effect and recurrence appear similar.
    J Radiat Oncol Volume: 4 Page(s): 235 - 241
    09/01/2015 Authors: Kleinberg LR; Stieber V; Mikkelsen T; Judy K; Weingart J; Barnett G; Olson J; Desideri S; Ye X; Grossman S
  • Complementary therapy and survival in glioblastoma.
    Neurooncol Pract Volume: 2 Page(s): 122 - 126
    09/01/2015 Authors: Mulpur BH; Nabors LB; Thompson RC; Olson JJ; LaRocca RV; Thompson Z; Egan KM
  • Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases.
    J Neurooncol Volume: 123 Page(s): 103 - 111
    05/01/2015 Authors: Eaton BR; LaRiviere MJ; Kim S; Prabhu RS; Patel K; Kandula S; Oyesiku N; Olson J; Curran W; Shu H-K
  • Erratum to: Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases.
    J Neurooncol Volume: 123 Page(s): 113
    05/01/2015 Authors: Eaton BR; LaRiviere MJ; Kim S; Prabhu RS; Patel K; Kandula S; Oyesiku N; Olson J; Curran W; Shu H-K
  • BAI1 regulates spatial learning and synaptic plasticity in the hippocampus.
    J Clin Invest Volume: 125 Page(s): 1497 - 1508
    04/01/2015 Authors: Zhu D; Li C; Swanson AM; Villalba RM; Guo J; Zhang Z; Matheny S; Murakami T; Stephenson JR; Daniel S
  • System a amino acid transport-targeted brain and systemic tumor PET imaging agents 2-amino-3-[(18)F]fluoro-2-methylpropanoic acid and 3-[(18)F]fluoro-2-methyl-2-(methylamino)propanoic acid.
    Nucl Med Biol Volume: 42 Page(s): 8 - 18
    01/01/2015 Authors: Yu W; McConathy J; Olson JJ; Goodman MM
  • Brain tumor risk according to germ-line variation in the MLLT10 locus.
    Eur J Hum Genet Volume: 23 Page(s): 132 - 134
    01/01/2015 Authors: Egan KM; Baskin R; Nabors LB; Thompson RC; Olson JJ; Browning JE; Madden MH; Monteiro AN
  • Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
    J Neurooncol Volume: 120 Page(s): 657 - 663
    12/01/2014 Authors: Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK
  • BAI1 IS A NEW TUMOR SUPPRESSOR IN MEDULLOBLASTOMA
    NEURO-ONCOLOGY Volume: 16
    11/01/2014 Authors: Zhu D; Zhang Z; Olson J; Van Meir E
  • USE OF VOLUMETRIC MR SPECTROSCOPIC IMAGING AND 5-ALA FLUORESCENCE-GUIDED SURGERY FOR RESECTION OF GLIOBLASTOMA
    Volume: 16
    11/01/2014 Authors: Cordova JS; Liang Z; Holder CA; Appin C; Schreibmann E; Bian X; Brat D; Shu H-K; Olson J; Maudsley A
  • GENDER AND REPRODUCTIVE FACTORS IN RELATION TO SURVIVAL IN GLIOBLASTOMA
    NEURO-ONCOLOGY Volume: 16
    11/01/2014 Authors: Egan K; Nabors LB; Olson J; LaRocca R; Thompson Z; Madden M; Thompson R
  • Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions.
    J Neurooncol Volume: 119 Page(s): 557 - 568
    09/01/2014 Authors: Linskey ME; Olson JJ; Mitchell LS; Kalkanis SN
  • Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor.
    AJR Am J Roentgenol Volume: 203 Page(s): W158 - W165
    08/01/2014 Authors: Shim H; Wei L; Holder CA; Guo Y; Hu XP; Miller AH; Olson JJ
  • The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 118 Page(s): 489 - 499
    07/01/2014 Authors: Ryu S; Buatti JM; Morris A; Kalkanis SN; Ryken TC; Olson JJ; AANS/CNS Joint Guidelines Committee
  • Glioblastoma at progression: therapy of a challenging problem addressed candidly with evidence-based techniques.
    J Neurooncol Volume: 118 Page(s): 427 - 428
    07/01/2014 Authors: Olson JJ
  • The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 118 Page(s): 479 - 488
    07/01/2014 Authors: Ryken TC; Kalkanis SN; Buatti JM; Olson JJ; AANS/CNS Joint Guidelines Committee
  • The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 118 Page(s): 557 - 599
    07/01/2014 Authors: Olson JJ; Nayak L; Ormond DR; Wen PY; Kalkanis SN; Ryken TC; AANS/CNS Joint Guidelines Committee
  • The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 118 Page(s): 501 - 555
    07/01/2014 Authors: Olson JJ; Nayak L; Ormond DR; Wen PY; Kalkanis SN; AANS/CNS Joint Guidelines Committee
  • The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 118 Page(s): 461 - 478
    07/01/2014 Authors: Brat DJ; Ryken TC; Kalkanis SN; Olson JJ; AANS/CNS Joint Guidelines Committee
  • The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 118 Page(s): 435 - 460
    07/01/2014 Authors: Ryken TC; Aygun N; Morris J; Schweizer M; Nair R; Spracklen C; Kalkanis SN; Olson JJ; AANS/CNS Joint Guidelines Committee
  • Introduction, rationale, and methodology.
    J Neurooncol Volume: 118 Page(s): 429 - 434
    07/01/2014 Authors: Olson JJ; Ryken TC; Kalkanis SN; AANS/CNS Joint Guidelines Committee
  • A novel p53 bystander effect induces glioblastoma cell death through a glycosylation-dependent mechanism.
    Neuro Oncol Volume: 16 Suppl 3 Page(s): iii19
    07/01/2014 Authors: Van Meir EG; Lee SH; Khwaja FW; Zerrouqi A; Zhang Z; Olson JJ; Kaluzova M; Hadjipanayis CG; Devi NS
  • SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression.
    Nat Commun Volume: 5 Page(s): 4234
    06/23/2014 Authors: Bellail AC; Olson JJ; Hao C
  • Reproductive factors and risk of primary brain tumors in women.
    J Neurooncol Volume: 118 Page(s): 297 - 304
    06/01/2014 Authors: Anic GM; Madden MH; Nabors LB; Olson JJ; LaRocca RV; Thompson ZJ; Pamnani SJ; Forsyth PA; Thompson RC; Egan KM
  • Current approaches to the treatment of metastatic brain tumours.
    Nat Rev Clin Oncol Volume: 11 Page(s): 203 - 222
    04/01/2014 Authors: Owonikoko TK; Arbiser J; Zelnak A; Shu H-KG; Shim H; Robin AM; Kalkanis SN; Whitsett TG; Salhia B; Tran NL
  • Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy.
    Int J Radiat Oncol Biol Phys Volume: 88 Page(s): 1004 - 1010
    04/01/2014 Authors: Press RH; Prabhu RS; Appin CL; Brat DJ; Shu H-KG; Hadjipanayis C; Olson JJ; Oyesiku NM; Curran WJ; Crocker I
  • Circadian pathway genes in relation to glioma risk and outcome.
    Cancer Causes Control Volume: 25 Page(s): 25 - 32
    01/01/2014 Authors: Madden MH; Anic GM; Thompson RC; Nabors LB; Olson JJ; Browning JE; Monteiro AN; Egan KM
  • Toenail iron, genetic determinants of iron status, and the risk of glioma.
    Cancer Causes Control Volume: 24 Page(s): 2051 - 2058
    12/01/2013 Authors: Anic GM; Madden MH; Thompson RC; Nabors LB; Olson JJ; Larocca RV; Browning JE; Brockman JD; Forsyth PA; Egan KM
  • The somatic genomic landscape of glioblastoma.
    Cell Volume: 155 Page(s): 462 - 477
    10/10/2013 Authors: Brennan CW; Verhaak RGW; McKenna A; Campos B; Noushmehr H; Salama SR; Zheng S; Chakravarty D; Sanborn JZ; Berman SH
  • Impact of FACBC PET in Imaging and GTV Design of Cerebral Gliomas
    Volume: 87 Page(s): S250 - S250
    10/01/2013 Authors: Marchan EM; Goodman MM; Schuster DM; Vakili J; Olson JJ; Hadjipanayis CG; Brat DJ; Curran WJ; Shu HG; Crocker IR
  • Intracranial Control for Adjuvant Whole Brain Radiation Therapy Versus Stereotactic Radiosurgery Alone for Resected Brain Metastases
    Volume: 87 Page(s): S565 - S565
    10/01/2013 Authors: Patel K; Prabhu R; Hadjipanayis C; Olson J; Oyesiku N; Curran W; Shu H; Crocker I
  • Patterns of Failure for Grade 2/3 Meningioma Treated With Reduced Margin Intensity Modulated Radiation Therapy
    Volume: 87 Page(s): S158 - S158
    10/01/2013 Authors: Press RH; Prabhu RS; Appin CL; Brat DJ; Shu HG; Hadjipanayis C; Olson JJ; Oyesiku NM; Curran WJ; Crocker I
  • Early life exposures and the risk of adult glioma.
    Eur J Epidemiol Volume: 28 Page(s): 753 - 758
    09/01/2013 Authors: Anic GM; Madden MH; Sincich K; Thompson RC; Nabors LB; Olson JJ; LaRocca RV; Browning JE; Pan E; Egan KM
  • Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management.
    CNS Oncol Volume: 2 Page(s): 393 - 396
    09/01/2013 Authors: Shim H; Holder CA; Olson JJ
  • Prediagnostic body weight and survival in high grade glioma.
    J Neurooncol Volume: 114 Page(s): 79 - 84
    08/01/2013 Authors: Siegel EM; Nabors LB; Thompson RC; Olson JJ; Browning JE; Madden MH; Han G; Egan KM
  • Neurological and functional outcomes of subdural hematoma evacuation in patients over 70 years of age.
    J Neurosci Rural Pract Volume: 4 Page(s): 250 - 256
    07/01/2013 Authors: Mulligan P; Raore B; Liu S; Olson JJ
  • Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.
    Brain Pathol Volume: 23 Page(s): 454 - 461
    07/01/2013 Authors: Appin CL; Gao J; Chisolm C; Torian M; Alexis D; Vincentelli C; Schniederjan MJ; Hadjipanayis C; Olson JJ; Hunter S
  • Genomic Characterization of Diffuse Astrocytoma by SNP-CN Arrays and Hot-Spot Mutation Sequencing
    Volume: 72 Page(s): 540 - 541
    06/01/2013 Authors: Rossi M; Appin C; Bellail A; Mann K; Saxe D; Hill C; Olson J; Hadjipanayis C; Hunter S; Brat D
  • SUMO1 Modification Stabilizes CDK6 Protein and Drives the Cell Cycle and Glioblastoma Progression
    Volume: 72 Page(s): 575 - 575
    06/01/2013 Authors: Bellail A; Olson J; Hao C
  • Anthropometric factors in relation to risk of glioma.
    Cancer Causes Control Volume: 24 Page(s): 1025 - 1031
    05/01/2013 Authors: Little RB; Madden MH; Thompson RC; Olson JJ; Larocca RV; Pan E; Browning JE; Egan KM; Nabors LB
  • Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples.
    Clin Chem Volume: 59 Page(s): 815 - 823
    05/01/2013 Authors: Didelot A; Kotsopoulos SK; Lupo A; Pekin D; Li X; Atochin I; Srinivasan P; Zhong Q; Olson J; Link DR
  • Toenail iron, genetic variation in iron status, and the risk and outcome of glioma
    Volume: 73
    04/15/2013 Authors: Anic GM; Thompson RC; Nabors LB; Olson JJ; Madden MH; Browning JE; Brockman JD; Forsyth PA; Egan KM
  • Single cell phenotypic heterogeneity as a prognostic factor in glioblastoma
    Volume: 73
    04/15/2013 Authors: Lloyd MC; Madden MH; Nabors LB; Thompson RC; Olson JJ; Carroll SL; Browning J; Epstein T; Gatenby RA; Egan KV
  • SWI/SNF gene variants and glioma risk and outcome.
    Cancer Epidemiol Volume: 37 Page(s): 162 - 165
    04/01/2013 Authors: Amankwah EK; Thompson RC; Nabors LB; Olson JJ; Browning JE; Madden MH; Egan KM
  • [Orbital invasion of a maxillary ameloblastoma].
    Ophthalmologe Volume: 110 Page(s): 251 - 254
    03/01/2013 Authors: Herwig MC; Fischer HP; Moore CE; Walsh MD; Olson JJ; Beitler JJ; Grossniklaus HE
  • Group independent component analysis and functional MRI examination of changes in language areas associated with brain tumors at different locations.
    PLoS One Volume: 8 Page(s): e59657
    01/01/2013 Authors: Wang L; Chen D; Yang X; Olson JJ; Gopinath K; Fan T; Mao H
  • Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1 interaction with cofactors p300/CBP.
    Clin Cancer Res Volume: 18 Page(s): 6623 - 6633
    12/15/2012 Authors: Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z
  • Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
    J Neurooncol Volume: 110 Page(s): 257 - 264
    11/01/2012 Authors: Grossmann KF; Colman H; Akerley WA; Glantz M; Matsuoko Y; Beelen AP; Yu M; De Groot JF; Aiken RD; Olson JJ
  • VITAMIN AND SUPPLEMENT USE AND SURVIVAL IN PATIENTS WITH GLIOBLASTOMA
    Volume: 14 Page(s): 22 - 22
    10/01/2012 Authors: Mulpur BH; Nabors LB; Egan KM; Browning JE; Olson JJ; Thompson RC; Madden MH
  • Early prediction of response to Vorinostat in an orthotopic rat glioma model.
    NMR Biomed Volume: 25 Page(s): 1104 - 1111
    09/01/2012 Authors: Wei L; Hong S; Yoon Y; Hwang SN; Park JC; Zhang Z; Olson JJ; Hu XP; Shim H
  • K-Ras mutation-mediated IGF-1-induced feedback ERK activation contributes to the rapalog resistance in pancreatic ductal adenocarcinomas.
    Cancer Lett Volume: 322 Page(s): 58 - 69
    09/01/2012 Authors: Wei F; Liu Y; Bellail AC; Olson JJ; Sun S-Y; Lu G; Ding L; Yuan C; Wang G; Hao C
  • An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome.
    Cancer Causes Control Volume: 23 Page(s): 1443 - 1449
    09/01/2012 Authors: Anic GM; Thompson RC; Nabors LB; Olson JJ; Browning JE; Madden MH; Murtagh FR; Forsyth PA; Egan KM
  • Re-examine tumor-induced alterations in hemodynamic responses of BOLD fMRI: implications in presurgical brain mapping.
    Acta Radiol Volume: 53 Page(s): 802 - 811
    09/01/2012 Authors: Wang L; Chen D; Olson J; Ali S; Fan T; Mao H
  • 111Magnetic Resonance Spectroscopic Imaging Measurement of Early Response to Vorinostat Treatment in Recurrent Glioblastoma.
    Volume: 71 Page(s): E546 - E547
    08/01/2012 Authors: Olson JJ; Voloschin A; Wei L; Miller A; Brat D; Holder C; Shu H-K; Hu X; Shim H
  • Rare TP53 genetic variant associated with glioma risk and outcome.
    J Med Genet Volume: 49 Page(s): 420 - 421
    07/01/2012 Authors: Egan KM; Nabors LB; Olson JJ; Monteiro AN; Browning JE; Madden MH; Thompson RC
  • SSBP2 variants are associated with survival in glioblastoma patients.
    Clin Cancer Res Volume: 18 Page(s): 3154 - 3162
    06/01/2012 Authors: Xiao Y; Decker PA; Rice T; McCoy LS; Smirnov I; Patoka JS; Hansen HM; Wiemels JL; Tihan T; Prados MD
  • Using proton MRSI to predict response to vorinostat treatment in recurrent GBM.
    Volume: 30
    05/20/2012 Authors: Shim H; Voloschin AD; Wei L; Hwang SN; Miller AH; Guo Y; Brat D; Holder CA; Read WL; Kopcewicz K
  • Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
    Int J Radiat Oncol Biol Phys Volume: 83 Page(s): e61 - e66
    05/01/2012 Authors: Prabhu R; Shu H-K; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
  • Rb-82 positron emission tomography for post radiotherapy brain tumor evaluation: A pilot study
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Amzat R; Taleghani P; Nye J; Savir-Baruch B; Holder C; Olson J; Crocker I; Voloschin A; Gavrikov V; Schuster D
  • A20 ubiquitin ligase-mediated RIP1 polyubiquitin chains inhibits TRAIL-induced apoptosis in glioblastoma
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
  • Premorbid body weight and survival in high grade glioma
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Siegel EM; Thompson RC; Nabors LB; Olson JJ; Madden MH; Browning JE; Pan E; Egan KM
  • Common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Anic GM; Thompson RC; Nabors LB; Olson JJ; Madden MH; Browning JE; Murtagh RF; Forsyth PA; Egan KM
  • Using proton MRSI to predict response of Vorinostat treatment in recurrent GBM
    CANCER RESEARCH Volume: 72
    04/15/2012 Authors: Shim H; Wei L; Hwang SN; Miller AH; Guo Y; Hoder CA; Read W; Kopcewicz K; Voloschin A; Brat DJ
  • RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells.
    Cancer Res Volume: 72 Page(s): 1221 - 1228
    03/01/2012 Authors: Zheng Z; Ng WL; Zhang X; Olson JJ; Hao C; Curran WJ; Wang Y
  • Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases.
    J Biol Chem Volume: 287 Page(s): 6113 - 6127
    02/24/2012 Authors: Qi Q; He K; Yoo M-H; Chan C-B; Liu X; Zhang Z; Olson JJ; Xiao G; Wang L; Mao H
  • A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
    Cancer Discov Volume: 2 Page(s): 140 - 155
    02/01/2012 Authors: Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
  • Impact of Oncogenic Alterations on MGMT Promoter Methylation Status in Glioblastoma (GBM)
    Volume: 92 Page(s): 435A - 435A
    02/01/2012 Authors: Rong Y; Vincentelli C; Chisolm C; Olson JJ; Hao C; Hunter SB; Brat DJ
  • Impact of Oncogenic Alterations on MGMT Promoter Methylation Status in Glioblastoma (GBM)
    Volume: 25 Page(s): 435A - 435A
    02/01/2012 Authors: Rong Y; Vincentelli C; Chisolm C; Olson JJ; Hao C; Hunter SB; Brat DJ
  • A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma.
    J Neurooncol Volume: 105 Page(s): 639 - 646
    12/01/2011 Authors: Permuth-Wey J; Thompson RC; Burton Nabors L; Olson JJ; Browning JE; Madden MH; Ann Chen Y; Egan KM
  • Metastasis infiltration: an investigation of the postoperative brain-tumor interface.
    Int J Radiat Oncol Biol Phys Volume: 81 Page(s): 1075 - 1080
    11/15/2011 Authors: Raore B; Schniederjan M; Prabhu R; Brat DJ; Shu H-K; Olson JJ
  • Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis.
    Apoptosis Volume: 16 Page(s): 1150 - 1164
    11/01/2011 Authors: Qi L; Bellail AC; Rossi MR; Zhang Z; Pang H; Hunter S; Cohen C; Moreno CS; Olson JJ; Li S
  • INHERITED VARIANTS IMPACT SURVIVAL IN UNIFORMLY TREATED GLIOBLASTOMA PATIENTS
    NEURO-ONCOLOGY Volume: 13 Page(s): 27 - 28
    11/01/2011 Authors: Xiao Y; Decker PA; Rice T; Hansen HM; Wiemels JL; Tihan T; Prados MD; Chang SM; Berger MS; Kosel ML
  • Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP.
    Cancer Invest Volume: 29 Page(s): 511 - 520
    10/01/2011 Authors: Ding L; Yuan C; Wei F; Wang G; Zhang J; Bellail AC; Zhang Z; Olson JJ; Hao C
  • Cancer susceptibility variants and the risk of adult glioma in a US case-control study.
    J Neurooncol Volume: 104 Page(s): 535 - 542
    09/01/2011 Authors: Egan KM; Thompson RC; Nabors LB; Olson JJ; Brat DJ; Larocca RV; Brem S; Moots PL; Madden MH; Browning JE
  • Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR.
    Lab Chip Volume: 11 Page(s): 2167 - 2174
    07/07/2011 Authors: Zhong Q; Bhattacharya S; Kotsopoulos S; Olson J; Taly V; Griffiths AD; Link DR; Larson JW
  • Genetic variation in the NOTCH stem cell signaling network in relation to risk of adult-onset glioma
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Madden MH; Thompson RC; Nabors LB; Olson JJ; Browning JE; Chen YA; Brat DJ; Egan KM
  • Genetic variation in the voltage-gated chloride channel family members CLCN2 and CLCN3 in relation to glioma risk and outcome
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Egan KM; Nabors LB; Olson JJ; Browning JE; Madden MH; Chen YA; Brem S; Brat DJ; Sontheimer H; Tran ND
  • Genetic variation in podoplanin in relation to glioma risk and outcome
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Niemeyer KN; Pan E; Thompson RC; Nabors LB; Olson JJ; Browning JE; Madden MH; Chen A; Yachnis AT; Egan KM
  • Genetic variation in the natural killer cell activating receptor NKG2D and its ligands in relation to glioma risk and outcome
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Browning JE; Thompson RC; Nabors LB; Olson JJ; Madden MH; Chen YA; Nickols HH; Egan KM
  • Case study: brain abscess without an obvious source of infection.
    J Med Assoc Ga Volume: 100 Page(s): 25
    01/01/2011 Authors: Tanaka T; Olson JJ
  • Current Dosing Paradigm For Stereotactic Radiosurgery Alone Following Surgical Resection of Brain Metastases Needs To Be Optimized For Improved Local Control
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S652 - S653
    01/01/2011 Authors: Prabhu RS; Hadjipanayis C; Shu H; Hall W; Raore B; Olson JJ; Curran W; Oyesiku N; Crocker I
  • Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.
    J Neurooncol Volume: 100 Page(s): 95 - 103
    10/01/2010 Authors: Phuphanich S; Supko JG; Carson KA; Grossman SA; Burt Nabors L; Mikkelsen T; Lesser G; Rosenfeld S; Desideri S; Olson JJ
  • Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion.
    Neurology Volume: 75 Page(s): 419 - 424
    08/03/2010 Authors: Schuette AJ; Taub JS; Hadjipanayis CG; Olson JJ
  • Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation.
    PLoS One Volume: 5 Page(s): e11397
    07/01/2010 Authors: Yan D; Ng WL; Zhang X; Wang P; Zhang Z; Mo Y-Y; Mao H; Hao C; Olson JJ; Curran WJ
  • ACR appropriateness criteria on metastatic bone disease.
    J Am Coll Radiol Volume: 7 Page(s): 400 - 409
    06/01/2010 Authors: Roberts CC; Daffner RH; Weissman BN; Bancroft L; Bennett DL; Blebea JS; Bruno MA; Fries IB; Germano IM; Holly L
  • DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
    J Cell Mol Med Volume: 14 Page(s): 1303 - 1317
    06/01/2010 Authors: Bellail AC; Tse MCL; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
  • A clinical study investigating MPC-6827 with carboplatin in the treatment of patients with relapsed glioblastoma multiforme.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 28
    05/20/2010 Authors: Grossmann KF; Ward JH; Akerley WL; Glantz MJ; De Groot JF; Aiken R; Olson JJ; Matsuoka Y; Yu MK; Jensen RL
  • Synthesis and biological evaluation of anti-1-amino-2-[18F]fluoro-cyclobutyl-1-carboxylic acid (anti-2-[18F]FACBC) in rat 9L gliosarcoma.
    Bioorg Med Chem Lett Volume: 20 Page(s): 2140 - 2143
    04/01/2010 Authors: Yu W; Williams L; Camp VM; Olson JJ; Goodman MM
  • Metastasis Infiltration: An Investigation of the Post-Operative Brain-Tumor Interface
    Volume: 90 Page(s): 381A - 381A
    02/01/2010 Authors: Schniederjan MJ; Raore B; Brat DJ; Shu HK; Olson JJ
  • Metastasis Infiltration: An Investigation of the Post-Operative Brain-Tumor Interface
    Volume: 23 Page(s): 381A - 381A
    02/01/2010 Authors: Schniederjan MJ; Raore B; Brat DJ; Shu HK; Olson JJ
  • Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors.
    J Med Chem Volume: 53 Page(s): 876 - 886
    01/28/2010 Authors: Yu W; McConathy J; Williams L; Camp VM; Malveaux EJ; Zhang Z; Olson JJ; Goodman MM
  • The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 96 Page(s): 17 - 32
    01/01/2010 Authors: Gaspar LE; Mehta MP; Patchell RA; Burri SH; Robinson PD; Morris RE; Ammirati M; Andrews DW; Asher AL; Cobbs CS
  • The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 96 Page(s): 33 - 43
    01/01/2010 Authors: Kalkanis SN; Kondziolka D; Gaspar LE; Burri SH; Asher AL; Cobbs CS; Ammirati M; Robinson PD; Andrews DW; Loeffler JS
  • Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.
    CA Cancer J Clin Volume: 60 Page(s): 166 - 193
    01/01/2010 Authors: Van Meir EG; Hadjipanayis CG; Norden AD; Shu H-K; Wen PY; Olson JJ
  • The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 96 Page(s): 71 - 83
    01/01/2010 Authors: Mehta MP; Paleologos NA; Mikkelsen T; Robinson PD; Ammirati M; Andrews DW; Asher AL; Burri SH; Cobbs CS; Gaspar LE
  • The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.
    J Neurooncol Volume: 96 Page(s): 115 - 142
    01/01/2010 Authors: Olson JJ; Paleologos NA; Gaspar LE; Robinson PD; Morris RE; Ammirati M; Andrews DW; Asher AL; Burri SH; Cobbs CS
  • The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 96 Page(s): 103 - 114
    01/01/2010 Authors: Ryken TC; McDermott M; Robinson PD; Ammirati M; Andrews DW; Asher AL; Burri SH; Cobbs CS; Gaspar LE; Kondziolka D
  • The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 96 Page(s): 97 - 102
    01/01/2010 Authors: Mikkelsen T; Paleologos NA; Robinson PD; Ammirati M; Andrews DW; Asher AL; Burri SH; Cobbs CS; Gaspar LE; Kondziolka D
  • The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 96 Page(s): 85 - 96
    01/01/2010 Authors: Ammirati M; Cobbs CS; Linskey ME; Paleologos NA; Ryken TC; Burri SH; Asher AL; Loeffler JS; Robinson PD; Andrews DW
  • The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
    J Neurooncol Volume: 96 Page(s): 45 - 68
    01/01/2010 Authors: Linskey ME; Andrews DW; Asher AL; Burri SH; Kondziolka D; Robinson PD; Ammirati M; Cobbs CS; Gaspar LE; Loeffler JS
  • ASSESSMENT OF THE EFFICACY OF ETOPOSIDE AND TEMSIROLIMUS IN AN INTRACRANIAL RODENT MODEL WITH SPECIAL ATTENTION TO THE RELATIONSHIP OF TUMOR AND WHITE CELL P70S6 KINASE ACTIVITY DURING THERAPY
    Volume: 11 Page(s): 907 - 907
    12/01/2009 Authors: Olson JJ; Zhang Z
  • NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM)
    Volume: 27
    05/20/2009 Authors: Nabors LB; Mikkelsen T; Batchelor T; Lesser G; Rosenfeld M; Ye X; Piantadosi S; Olson J; Brem S; Grossman S
  • NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM).
    J Clin Oncol Volume: 27 Page(s): 2001
    05/20/2009 Authors: Nabors LB; Mikkelsen T; Batchelor T; Lesser G; Rosenfeld M; Ye X; Piantadosi S; Olson J; Brem S; Grossman S
  • Using Proton MRS to predict responses of SAHA treatment in glioblastoma
    CANCER RESEARCH Volume: 69
    05/01/2009 Authors: Yoon Y; Wei L; Zhang Z; Harvey RD; Park J; Olson J; Hu X; Shim H
  • Management of newly diagnosed glioblastoma: guidelines development, value and application.
    J Neurooncol Volume: 93 Page(s): 1 - 23
    05/01/2009 Authors: Olson JJ; Fadul CE; Brat DJ; Mukundan S; Ryken TC
  • (S)- and (R)-[18F]NMeFAMP: PET brain tumor imaging agents
    Volume: 50
    05/01/2009 Authors: Yu W; McConathy J; Olson J; Goodman M
  • GENETIC AND HYPOXIC MECHANISMS OF TISSUE FACTOR EXPRESSION AND THROMBOSIS IN GLIOBLASTOMA
    Volume: 11 Page(s): 220 - 220
    04/01/2009 Authors: Brat DJ; Rong Y; Olson JJ; Belozerov VE; Chen G; Durden DL; Van Meir EG
  • Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
    Cancer Res Volume: 69 Page(s): 2540 - 2549
    03/15/2009 Authors: Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
  • Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent.
    Bioorg Med Chem Volume: 17 Page(s): 1982 - 1990
    03/01/2009 Authors: Yu W; Williams L; Camp VM; Malveaux E; Olson JJ; Goodman MM
  • Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.
    Cancer Res Volume: 69 Page(s): 1212 - 1220
    02/01/2009 Authors: Kaur B; Cork SM; Sandberg EM; Devi NS; Zhang Z; Klenotic PA; Febbraio M; Shim H; Mao H; Tucker-Burden C
  • STEREOSPECIFIC SYNTHESIS AND IN VITRO EVALUATION OF (S)/(R)-[123I]IVAIB FOR TUMOR IMAGING WITH SPECT
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS Volume: 52 Page(s): S412 - S412
    01/01/2009 Authors: Yu W; Williams L; Camp VM; Malveaux E; Zhang Z; Olson J; Goodman MM
  • Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study.
    J Neurooncol Volume: 91 Page(s): 51 - 58
    01/01/2009 Authors: Blakeley JO; Olson J; Grossman SA; He X; Weingart J; Supko JG; New Approaches to Brain Tumor Therapy (NABTT) Consortium
  • Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme.
    J Neurooncol Volume: 90 Page(s): 293 - 299
    12/01/2008 Authors: Olson JJ; McKenzie E; Skurski-Martin M; Zhang Z; Brat D; Phuphanich S
  • Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
    Nature Volume: 455 Page(s): 1061 - 1068
    10/23/2008 Authors: Cancer Genome Atlas Research Network
  • PRECLINICAL ANALYSIS OF DEPOCYT THERAPY FOR INTRACEREBRAL TUMORS
    Volume: 10 Page(s): 789 - 789
    10/01/2008 Authors: Olson J; Zhang Z; Hadjipanayis C; New P
  • PROTEOMIC ANALYSIS OF PROTEINS SECRETED BY GLIOBLASTOMA THAT INDUCE ENDOTHELIAL TISSUE FACTOR EXPRESSION
    Volume: 10 Page(s): 800 - 800
    10/01/2008 Authors: Rong Y; Tucker-Burden C; Chen G; Durden DL; Olson J; Van Meir E; Pohl J; Brat DJ
  • Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme.
    J Neurooncol Volume: 89 Page(s): 339 - 357
    09/01/2008 Authors: Fadul CE; Wen PY; Kim L; Olson JJ
  • Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults.
    J Neurooncol Volume: 89 Page(s): 313 - 337
    09/01/2008 Authors: Buatti J; Ryken TC; Smith MC; Sneed P; Suh JH; Mehta M; Olson JJ
  • Diagnosis of malignant glioma: role of neuropathology.
    J Neurooncol Volume: 89 Page(s): 287 - 311
    09/01/2008 Authors: Brat DJ; Prayson RA; Ryken TC; Olson JJ
  • Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery.
    J Neurooncol Volume: 89 Page(s): 271 - 286
    09/01/2008 Authors: Ryken TC; Frankel B; Julien T; Olson JJ
  • Neuroradiological assessment of newly diagnosed glioblastoma.
    J Neurooncol Volume: 89 Page(s): 259 - 269
    09/01/2008 Authors: Mukundan S; Holder C; Olson JJ
  • Guidelines for the treatment of newly diagnosed glioblastoma: introduction.
    J Neurooncol Volume: 89 Page(s): 255 - 258
    09/01/2008 Authors: Olson JJ; Ryken T
  • Assessment of a balloon-tipped catheter modified for intracerebral convection-enhanced delivery.
    J Neurooncol Volume: 89 Page(s): 159 - 168
    09/01/2008 Authors: Olson JJ; Zhang Z; Dillehay D; Stubbs J
  • Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.
    Neuro Oncol Volume: 10 Page(s): 617 - 623
    08/01/2008 Authors: Phuphanich S; Carson KA; Grossman SA; Lesser G; Olson J; Mikkelsen T; Desideri S; Fisher JD; New Approaches to Brain Tumor Therapy (NABTT) CNS Consortium
  • Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma.
    Neuro Oncol Volume: 10 Page(s): 190 - 198
    04/01/2008 Authors: Grossman SA; Olson J; Batchelor T; Peereboom D; Lesser G; Desideri S; Ye X; Hammour T; Supko JG; New Approaches to Brain Tumor Therapy CNS Consortium
  • Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioblastoma.
    Brain Pathol Volume: 18 Page(s): 164 - 171
    04/01/2008 Authors: Tehrani M; Friedman TM; Olson JJ; Brat DJ
  • Synthesis and evaluation of [123I] labeled iodovinyl amino acids syn-, anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents.
    Bioorg Med Chem Lett Volume: 18 Page(s): 1264 - 1268
    02/15/2008 Authors: Yu W; Williams L; Malveaux E; Camp VM; Olson JJ; Goodman MM
  • Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography.
    J Med Chem Volume: 50 Page(s): 6718 - 6721
    12/27/2007 Authors: Yu W; McConathy J; Olson J; Camp VM; Goodman MM
  • NABTT 0502: Phase 2 trial of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme
    Volume: 9 Page(s): 525 - 525
    10/01/2007 Authors: Peereboom D; Olson J; Nabors B; Rosenfeld M; Mikkelsen T; Ye X; Grossman S
  • Targeted cancer-gene therapy using a HIF-dependent oncolytic adenovirus armed with interleukin-4
    Volume: 9 Page(s): 490 - 490
    10/01/2007 Authors: Kyle M; Zhang Z; Sandberg E; Devi N; Brat DJ; Xu Z; Tighiouart M; Olson J; Van Meir E; Post D
  • Intravascular thrombosis is more frequent in glioblastoma than other central nervous system malignancies
    Volume: 66 Page(s): 427 - 427
    05/01/2007 Authors: Tehrani M; Friedman TM; Olson JJ; Brat DJ
  • Intravascular thrombosis is more frequent in glioblastoma than other central nervous system malignancies
    Volume: 21 Page(s): A26 - A26
    04/01/2007 Authors: Tehrani M; Friedman TM; Olson JJ; Brat DJ
  • Intravascular thrombosis in central nervous system malignancies
    Volume: 87 Page(s): 302A - 302A
    03/01/2007 Authors: Tehrani M; Olson JJ; Brat DJ
  • Intravascular thrombosis in central nervous system malignancies
    Volume: 20 Page(s): 302A - 302A
    03/01/2007 Authors: Tehrani M; Olson JJ; Brat DJ
  • Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients.
    J Proteome Res Volume: 6 Page(s): 559 - 570
    02/01/2007 Authors: Khwaja FW; Reed MS; Olson JJ; Schmotzer BJ; Gillespie GY; Guha A; Groves MD; Kesari S; Pohl J; Van Meir EG
  • Association between an arachnoid cyst and intracranial aneurysms misdiagnosed as a cystic tumor with a mural nodule. Case report and review of the literature.
    Neurosurg Focus Volume: 22 Page(s): E3
    01/01/2007 Authors: Chhabra VS; Zhang J; Olson JJ
  • Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.
    Cancer Res Volume: 66 Page(s): 11991 - 11997
    12/15/2006 Authors: Kang S-H; Cho HT; Devi S; Zhang Z; Escuin D; Liang Z; Mao H; Brat DJ; Olson JJ; Simons JW
  • Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers.
    Proteomics Volume: 6 Page(s): 6277 - 6287
    12/01/2006 Authors: Khwaja FW; Nolen JDL; Mendrinos SE; Lewis MM; Olson JJ; Pohl J; Van Meir EG; Ritchie JC; Brat DJ
  • Identificatoin of glioma-motility factor, attractin, and other new protein biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients
    Volume: 8 Page(s): 422 - 422
    10/01/2006 Authors: Khwaja FW; Reed M; Duke-Cohan JS; Brat DJ; Schmotzer BJ; Olson JJ; Gillespie GY; Guha A; Groves MD; Pohl J
  • Phase I analysis of systemic interferon alpha (IFN alpha) following BCNU polymer implantation in subjects with recurrent malignant gliomas
    Volume: 8 Page(s): 449 - 449
    10/01/2006 Authors: Phuphanich S; Zhang Z; Brat D; McKenzie E; Olson J
  • Differences in the distribution of methotrexate into high grade gliomas following intravenous administration, as monitored by microdialysis, are associated with blood brain barrier integrity.
    Volume: 24 Page(s): 70S - 70S
    06/20/2006 Authors: Olson JJ; Blakeley JO; Grossman SA; Weingart J; Rashid A; Supko J
  • Phase I analysis of systemic interferon alpha utilized with gliadel in adults with recurrent glioblastoma multiforme (GBM).
    J Clin Oncol Volume: 24 Page(s): 11508
    06/20/2006 Authors: Lawson DH; Phuphanich S; McKenzie E; Greiner K; Shires K; Olson JJ
  • Differences in the distribution of methotrexate into high grade gliomas following intravenous administration, as monitored by microdialysis, are associated with blood brain barrier integrity.
    J Clin Oncol Volume: 24 Page(s): 1548
    06/20/2006 Authors: Olson JJ; Blakeley JO; Grossman SA; Weingart J; Rashid A; Supko J; Nabtt CNS Consortium
  • DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests.
    Diagn Mol Pathol Volume: 14 Page(s): 183 - 191
    09/01/2005 Authors: Olson J; Whitney DH; Durkee K; Shuber AP
  • Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    J Histochem Cytochem Volume: 53 Page(s): 963 - 969
    08/01/2005 Authors: Hunter SB; Varma V; Shehata B; Nolen JDL; Cohen C; Olson JJ; Ou C-Y
  • Development of TRAIL therapeutic strategies for malignant gliomas
    Volume: 7 Page(s): 384 - 384
    07/01/2005 Authors: Song JH; Song D; Lin C; Phuphanich S; Brat D; Olson J; Van Meir E; Hao C
  • A phase I evaluation of the safety of escalating doses of atrasentan in adults with recurrent malignant glioma (MG)
    Volume: 23 Page(s): 120S - 120S
    06/01/2005 Authors: Phuphanich S; Carson K; Grossman S; Lesser G; Olson J; Mikkelsen T; Desideri S; Fisher JD
  • Intratumoral pharmacokinetics determined with microdialysis in a patient with glioblastoma multiforme following systemic administration of high dose methotrexate.
    Volume: 23 Page(s): 131S - 131S
    06/01/2005 Authors: Olson JJ; Supko J; Phuphanich S; McKenzie E; Grossman SA
  • Does phenytoin does affect celecoxib pharmacokinetics in patients with newly diagnosed glioblastoma multiforme?
    Volume: 23 Page(s): 156S - 156S
    06/01/2005 Authors: Grossman SA; Olson J; Batchelor T; Peereboom D; Lesser G; Desideri S; Ye X; Hammour T; Supko JG
  • Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
    Cancer Res Volume: 65 Page(s): 605 - 612
    01/15/2005 Authors: Tan C; de Noronha RG; Roecker AJ; Pyrzynska B; Khwaja F; Zhang Z; Zhang H; Teng Q; Nicholson AC; Giannakakou P
  • Benefit of temozolomide compared to procarbazine in treatment of glioblastoma multiforme at first relapse: effect on neurological functioning, performance status, and health related quality of life.
    Cancer Invest Volume: 23 Page(s): 138 - 144
    01/01/2005 Authors: Macdonald DR; Kiebert G; Prados M; Yung A; Olson J
  • Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors.
    Clin Cancer Res Volume: 10 Page(s): 8603 - 8612
    12/15/2004 Authors: Post DE; Devi NS; Li Z; Brat DJ; Kaur B; Nicholson A; Olson JJ; Zhang Z; Van Meir EG
  • A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.
    Mol Ther Volume: 10 Page(s): 958 - 966
    11/01/2004 Authors: Chiocca EA; Abbed KM; Tatter S; Louis DN; Hochberg FH; Barker F; Kracher J; Grossman SA; Fisher JD; Carson K
  • Diagnostic potential of proteomic analysis of cerebrospinal fluid (CSF) from glioma patients
    Volume: 6 Page(s): 338 - 338
    10/01/2004 Authors: Khwaja FW; Olson JJ; Brat DJ; Mendrinos S; van Meir EG
  • Schwannoma protein and mRNA expression and cellular proliferation in relationship to hypoxia and erythropoetin
    Volume: 6 Page(s): 320 - 320
    10/01/2004 Authors: Olson JJ; Zhang ZB; Mattox D
  • Correlation of the response of recurrent malignant gliomas treated with interferon alpha with tumor interferon alpha gene content.
    Int J Oncol Volume: 25 Page(s): 419 - 427
    08/01/2004 Authors: Olson JJ; James CD; Lawson D; Hunter S; Tang G; Billingsley J
  • Delivery systems and molecular targets of mechanism-based therapies for GBM.
    Expert Rev Neurother Volume: 4 Page(s): 649 - 663
    07/01/2004 Authors: Phuphanich S; Brat DJ; Olson JJ
  • Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes.
    Exp Neurol Volume: 188 Page(s): 94 - 103
    07/01/2004 Authors: Junge CE; Lee CJ; Hubbard KB; Zhang Z; Olson JJ; Hepler JR; Brat DJ; Traynelis SF
  • Tissue disposition of 5-o-carboranyluracil--a novel agent for the boron neutron capture therapy of prostate cancer.
    Nucleosides Nucleotides Nucleic Acids Volume: 23 Page(s): 291 - 306
    01/01/2004 Authors: Schinazi RF; Hurwitz SJ; Liberman I; Glazkova Y; Mourier NS; Olson J; Keane T
  • Safety and efficacy of concurrent interstitial radiation and hyperthermia in the treatment of progressive malignant brain tumors.
    Oncol Rep Volume: 11 Page(s): 97 - 103
    01/01/2004 Authors: Narayan P; Crocker I; Elder E; Olson JJ
  • Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review).
    Int J Oncol Volume: 23 Page(s): 857 - 869
    10/01/2003 Authors: Hunter SB; Brat DJ; Olson JJ; Von Deimling A; Zhou W; Van Meir EG
  • An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
    J Neurosurg Volume: 99 Page(s): 297 - 303
    08/01/2003 Authors: Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL
  • Synthesis and evaluation of 2-amino-4-[(18)F]fluoro-2-methylbutanoic acid (FAMB): relationship of amino acid transport to tumor imaging properties of branched fluorinated amino acids.
    Nucl Med Biol Volume: 30 Page(s): 477 - 490
    07/01/2003 Authors: McConathy J; Martarello L; Malveaux EJ; Camp VM; Simpson NE; Simpson CP; Bowers GD; Zhang Z; Olson JJ; Goodman MM
  • Uptake of the synthetic PET amino acid radiotracer 1-amino-3-[F-18]fluorocyclobutane-1-carboxylic acid (F-18-FACBC) within primary and metastatic brain cancer compared with 18F-fluorodeoxyglucose (F-18-FDG).
    Volume: 44 Page(s): 167P - 167P
    05/01/2003 Authors: Schuster DM; Votaw JR; Halkar RK; McConathy J; Crowe RJ; Olson J; Goodman MM
  • Validation of human estimated radiation dosimetry from animal data for the synthetic PET amino acid radiotracer 1-amino-3-[F-18]fluorocyclobutane-1-carboxylic acid (F-18-FACBC).
    Volume: 44 Page(s): 322P - 323P
    05/01/2003 Authors: Schuster DM; Votaw JR; Halkar RK; McConathy J; Crowe RJ; Olson J; Goodman MM
  • Efficacy of adenoviral p53 delivery with SCH58500 in the intracranial 9l and RG2 models.
    Front Biosci Volume: 8 Page(s): a54 - a61
    05/01/2003 Authors: Bowers G; He J; Schulz K; Olivarria G; Maneval D; Olson JJ
  • Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial.
    J Neurosurg Volume: 98 Page(s): 725 - 730
    04/01/2003 Authors: Zabramski JM; Whiting D; Darouiche RO; Horner TG; Olson J; Robertson C; Hamilton AJ
  • Tumor Young Investigator Award: induction of glioblastoma multiforme in primates after fractionated whole-brain irradiation in the therapeutic dose range.
    Clin Neurosurg Volume: 50 Page(s): 350 - 373
    01/01/2003 Authors: Lonser RR; Walbridge S; Vortmeyer AO; Pack SD; Nguyen TT; Gogate N; Olson JJ; Akbasak A; Bobo RH; Goffman T
  • Induction of glioblastoma multiforme in nonhuman primates after therapeutic doses of fractionated whole-brain radiation therapy.
    J Neurosurg Volume: 97 Page(s): 1378 - 1389
    12/01/2002 Authors: Lonser RR; Walbridge S; Vortmeyer AO; Pack SD; Nguyen TT; Gogate N; Olson JJ; Akbasak A; Bobo RH; Goffman T
  • A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy.
    Neuro Oncol Volume: 4 Page(s): 261 - 267
    10/01/2002 Authors: Gilbert MR; Friedman HS; Kuttesch JF; Prados MD; Olson JJ; Reaman GH; Zaknoen SL
  • Results of interstitial brachytherapy for malignant brain tumors.
    Int J Oncol Volume: 21 Page(s): 817 - 823
    10/01/2002 Authors: Mayr MT; Crocker IR; Butker EK; Williams H; Cotsonis GA; Olson JJ
  • The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Neurosurgery Volume: 51 Page(s): 343 - 355
    08/01/2002 Authors: Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J
  • Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential PET ligands for tumor detection.
    J Med Chem Volume: 45 Page(s): 2250 - 2259
    05/23/2002 Authors: Martarello L; McConathy J; Camp VM; Malveaux EJ; Simpson NE; Simpson CP; Olson JJ; Bowers GD; Goodman MM
  • Radiolabeled amino acids for tumor imaging with PET: radiosynthesis and biological evaluation of 2-amino-3-[18F]fluoro-2-methylpropanoic acid and 3-[18F]fluoro-2-methyl-2-(methylamino)propanoic acid.
    J Med Chem Volume: 45 Page(s): 2240 - 2249
    05/23/2002 Authors: McConathy J; Martarello L; Malveaux EJ; Camp VM; Simpson NE; Simpson CP; Bowers GD; Olson JJ; Goodman MM
  • Uptake profiles of six F-18-labeled amino acids for tumor imaging: Comparison of in vitro and in vivo uptake of branched chain and cyclobutyl amino acids by 9L gliosarcoma tumor cells.
    JOURNAL OF NUCLEAR MEDICINE Volume: 43 Page(s): 41P - 41P
    05/01/2002 Authors: McConathy J; Martarello L; Simpson NE; Simpson CP; Malveaux EJ; Yu WP; Camp VM; Bowers GD; Olson JJ; Goodman MM
  • Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.
    J Neuropathol Exp Neurol Volume: 61 Page(s): 275 - 281
    03/01/2002 Authors: Hunter S; Young A; Olson J; Brat DJ; Bowers G; Wilcox JN; Jaye D; Mendrinos S; Neish A
  • Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities.
    J Neurosurg Volume: 96 Page(s): 335 - 343
    02/01/2002 Authors: Stubbs JB; Frankel RH; Schultz K; Crocker I; Dillehay D; Olson JJ
  • Development of brain tumor therapy with proteosome inhibitors
    INTERNATIONAL JOURNAL OF CANCER Page(s): 267 - 268
    01/01/2002 Authors: Olson JJ; Bowers G; Zhang Z
  • Development of a multi-modality device for local delivery of brain tumor therapies
    INTERNATIONAL JOURNAL OF CANCER Page(s): 267 - 267
    01/01/2002 Authors: Olson JJ; Stubbs J; Olavarria G; Bowers G; Narayan P; Zhang Z; Salazar B
  • Considerations in the diagnosis and management of brain metastases - The Sawaya article reviewed
    ONCOLOGY-NEW YORK Volume: 15 Page(s): 1164 - 1165
    09/01/2001 Authors: Olson JJ
  • Sinonasal undifferentiated carcinoma with orbital invasion: report of three cases.
    Ophthalmic Plast Reconstr Surg Volume: 17 Page(s): 288 - 292
    07/01/2001 Authors: Sharara N; Muller S; Olson J; Grist WJ; Grossniklaus HE
  • Loss of brain angiogenesis inhibitor-1 (BAI1) in glioblastoma multiforme.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 60 Page(s): 537 - 537
    05/01/2001 Authors: Brat DJ; Kaur B; Calkins CC; Medina-Flores R; Olson JJ; Van Meir EG
  • Expression microarray analysis: Pilocytic astrocytomas and oligodendrogliomas compared with anaplastic astrocytomas.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 60 Page(s): 534 - 534
    05/01/2001 Authors: Hunter S; Young A; Olson J; Van Meir E; Brat D; Bower G; Mendrinos S; Neish A
  • Preclinical development of ss-D-5-o-carboranyl-2'-deoxyuridine (D-CDU) for the treatment of malignant brain tumors
    Page(s): 1121 - 1124
    01/01/2001 Authors: Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis A; Shi JX; Liotta DC; Coderre J; Olson J
  • Extraneural metastatic glioblastoma after interstitial brachytherapy.
    Int J Radiat Oncol Biol Phys Volume: 48 Page(s): 831 - 836
    10/01/2000 Authors: Houston SC; Crocker IR; Brat DJ; Olson JJ
  • Neurosurgical advances in the treatment of brain tumors.
    Curr Oncol Rep Volume: 2 Page(s): 434 - 437
    09/01/2000 Authors: Olson JJ
  • A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse.
    Br J Cancer Volume: 83 Page(s): 588 - 593
    09/01/2000 Authors: Yung WK; Albright RE; Olson J; Fredericks R; Fink K; Prados MD; Brada M; Spence A; Hohl RJ; Shapiro W
  • Cloning of neuronal mtDNA variants in cultured cells by synaptosome fusion with mtDNA-less cells.
    Nucleic Acids Res Volume: 28 Page(s): 2164 - 2170
    05/15/2000 Authors: Trounce I; Schmiedel J; Yen HC; Hosseini S; Brown MD; Olson JJ; Wallace DC
  • Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
    Clin Cancer Res Volume: 6 Page(s): 725 - 730
    02/01/2000 Authors: Schinazi RF; Hurwitz SJ; Liberman I; Juodawlkis AS; Tharnish P; Shi J; Liotta DC; Coderre JA; Olson J
  • Intracranial extraskeletal mesenchymal chondrosarcoma: case report.
    Neurosurgery Volume: 46 Page(s): 207 - 211
    01/01/2000 Authors: Bingaman KD; Alleyne CH; Olson JJ
  • Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
    J Clin Oncol Volume: 17 Page(s): 2762 - 2771
    09/01/1999 Authors: Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM
  • Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.
    Int J Oncol Volume: 15 Page(s): 547 - 553
    09/01/1999 Authors: James CD; Galanis E; Frederick L; Kimmel DW; Cunningham JM; Atherton-Skaff PJ; O'Fallon JR; Jenkins RB; Buckner JC; Hunter SB
  • Analysis of cyclin dependent kinase inhibitors in malignant astrocytomas.
    Int J Oncol Volume: 14 Page(s): 1111 - 1116
    06/01/1999 Authors: Alleyne CH; He J; Yang J; Hunter SB; Cotsonis G; James CD; Olson JJ
  • Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.
    J Nucl Med Volume: 40 Page(s): 331 - 338
    02/01/1999 Authors: Shoup TM; Olson J; Hoffman JM; Votaw J; Eshima D; Eshima L; Camp VM; Stabin M; Votaw D; Goodman MM
  • Lipomatous glioneurocytoma of the posterior fossa with divergent differentiation: case report.
    Neurosurgery Volume: 42 Page(s): 639 - 643
    03/01/1998 Authors: Alleyne CH; Hunter S; Olson JJ; Barrow DL
  • Direct intracerebral delivery of carboplatin from PLGA microspheres against experimental malignant glioma in rats.
    Drug Deliv Volume: 5 Page(s): 101 - 110
    01/01/1998 Authors: Chen W; He J; Olson JJ; Lu DR
  • Gene amplification as a prognostic factor in primary brain tumors.
    Clin Cancer Res Volume: 4 Page(s): 215 - 222
    01/01/1998 Authors: Olson JJ; Barnett D; Yang J; Assietti R; Cotsonis G; James CD
  • Synthesis and evaluation of [F-18]-1-amino-3-fluorocyclopentane-1-carboxylic acid (FACPC) for tumor imaging and skeletal muscle metabolic studies by PET
    JOURNAL OF NUCLEAR MEDICINE Volume: 38 Page(s): 501 - 501
    05/01/1997 Authors: Shoup TM; Eshima D; Eshima L; Olson J; Camp VM; Goodman MM
  • Initial evaluation of high energy NaI-based coincidence brain imaging of tumor amino acid uptake and striatal dopamine transporters with [F-18]FACBC and [F-18]FECNT.
    JOURNAL OF NUCLEAR MEDICINE Volume: 38 Page(s): 619 - 619
    05/01/1997 Authors: Goodman MM; Shoup TM; Cullom SJ; Votaw J; Shi B; Olson J; White M; Votaw D; Eshima D; Giroux M
  • The EasyGuide Neuro image-guided surgery system.
    Neurosurgery Volume: 40 Page(s): 1092 - 1096
    05/01/1997 Authors: Olson JJ; Shepherd S; Bakay RA
  • Stereotactic radiosurgery of malignant and benign intracranial lesions utilizing a patient rotator.
    Radiat Oncol Investig Volume: 5 Page(s): 20 - 30
    01/01/1997 Authors: Alleyne CH; Fox TH; Olson JJ; Cotsonis GA; Crocker I; Bakay RA
  • Carboplatin-Loaded PLGA Microspheres for Intracerebral Implantation: In Vivo Characterization.
    Drug Deliv Volume: 4 Page(s): 301 - 311
    01/01/1997 Authors: Chen W; He J; Olson JJ; Lu DR
  • Quantification and pharmacokinetics of blood-brain barrier disruption in humans.
    J Neurosurg Volume: 85 Page(s): 1056 - 1065
    12/01/1996 Authors: Znkeler B; Carson RE; Olson J; Blasberg RG; DeVroom H; Lutz RJ; Saris SC; Wright DC; Kammerer W; Patronas NJ
  • Transfection of IFNalpha in human glioblastoma cells and tumorigenicity in association with induction of PKR and OAS gene expression.
    J Neurosurg Volume: 85 Page(s): 1085 - 1090
    12/01/1996 Authors: He J; Olson JJ; Ekstrand AJ; Serbanescu A; Yang J; Offermann MK; James CD
  • Molecular genetics and molecular biology advances in brain tumors.
    Curr Opin Oncol Volume: 8 Page(s): 188 - 195
    05/01/1996 Authors: James CD; Olson JJ
  • Intra-arterial cisplatin in malignant brain tumors: incidence and severity of otic toxicity.
    J Neurooncol Volume: 27 Page(s): 251 - 258
    03/01/1996 Authors: Assietti R; Olson JJ
  • Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
    J Neurosurg Volume: 84 Page(s): 494 - 502
    03/01/1996 Authors: Znkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
  • Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines.
    Cancer Res Volume: 55 Page(s): 4833 - 4836
    11/01/1995 Authors: He J; Olson JJ; James CD
  • Metastatic follicular thyroid carcinoma masquerading as a chordoma.
    Thyroid Volume: 5 Page(s): 217 - 221
    06/01/1995 Authors: Casals MM; Hunter SB; Olson JJ; Gussack G; Blevins LS
  • Analysis of epidermal growth factor receptor gene amplification and alteration in stereotactic biopsies of brain tumors.
    Neurosurgery Volume: 36 Page(s): 740 - 746
    04/01/1995 Authors: Olson JJ; James CD; Krisht A; Barnett D; Hunter S
  • Isolation and culture of bovine intracranial arterial endothelial cells.
    Neurosurgery Volume: 36 Page(s): 806 - 812
    04/01/1995 Authors: Reisner A; Olson JJ; Yang J; Assietti R; Klemm JM; Girard PR
  • Low-grade astrocytomas arising from the pineal gland.
    Surg Neurol Volume: 43 Page(s): 70 - 75
    01/01/1995 Authors: Barnett DW; Olson JJ; Thomas WG; Hunter SB
  • Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue.
    J Neuropathol Exp Neurol Volume: 54 Page(s): 57 - 64
    01/01/1995 Authors: Hunter SB; Abbott K; Varma VA; Olson JJ; Barnett DW; James CD
  • Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification.
    Oncogene Volume: 9 Page(s): 2313 - 2320
    08/01/1994 Authors: Ekstrand AJ; Longo N; Hamid ML; Olson JJ; Liu L; Collins VP; James CD
  • Laboratory evidence for the hormonal dependency of meningiomas.
    Hum Reprod Volume: 9 Suppl 1 Page(s): 195 - 201
    06/01/1994 Authors: Olson JJ
  • The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma.
    Neurosurgery Volume: 34 Page(s): 297 - 308
    02/01/1994 Authors: Olson JJ; Polk DM; Reisner A
  • Basic fibroblastic growth factor as a potential meningeal angiogenic factor.
    Skull Base Surg Volume: 3 Page(s): 117 - 122
    01/01/1993 Authors: Olson JJ; Reisner A; Klemm JM; Bakay RA
  • Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures.
    J Urol Volume: 148 Page(s): 910 - 914
    09/01/1992 Authors: Gansler T; Vaghmar N; Olson JJ; Graham SD
  • The cerebral radioprotective effect of alternative barbiturates to pentobarbital.
    Neurosurgery Volume: 30 Page(s): 720 - 723
    05/01/1992 Authors: Olson JJ; Shelley C; Orr K; DeLaney T; Oldfield EH
  • Enhancement of the efficacy of x-irradiation by pentobarbital in a rodent brain-tumor model.
    J Neurosurg Volume: 72 Page(s): 745 - 748
    05/01/1990 Authors: Olson JJ; Friedman R; Orr K; Delaney T; Oldfield EH
  • Reduction in radiation-induced brain injury by use of pentobarbital or lidocaine protection.
    J Neurosurg Volume: 72 Page(s): 737 - 744
    05/01/1990 Authors: Oldfield EH; Friedman R; Kinsella T; Moquin R; Olson JJ; Orr K; DeLuca AM
  • Cerebral radioprotection by pentobarbital: dose-response characteristics and association with GABA agonist activity.
    J Neurosurg Volume: 72 Page(s): 749 - 758
    05/01/1990 Authors: Olson JJ; Friedman R; Orr K; Delaney T; Oldfield EH
  • Metastatic pheochromocytoma of the cervical spine.
    Spine (Phila Pa 1976) Volume: 14 Page(s): 349 - 351
    03/01/1989 Authors: Olson JJ; Loftus CM; Hitchon PW
  • Androgen receptors in meningiomas.
    Cancer Volume: 61 Page(s): 952 - 955
    03/01/1988 Authors: Olson JJ; Beck DW; MacIndoe JW; Min-Loh P
  • Methylprednisolone reduces the bulk flow of water across an in vitro blood-brain barrier.
    Brain Res Volume: 439 Page(s): 259 - 265
    01/26/1988 Authors: Olson JJ; Poor MM; Beck DW
  • The role of new vessels and macrophages in the development and resolution of edema following a cortical freeze lesion in the mouse.
    J Neuropathol Exp Neurol Volume: 46 Page(s): 682 - 694
    11/01/1987 Authors: Olson JJ; Beck DW; Warner DS; Coester H
  • Comparative evaluation of intracranial epidermoid tumors with computed tomography and magnetic resonance imaging.
    Neurosurgery Volume: 21 Page(s): 357 - 360
    09/01/1987 Authors: Olson JJ; Beck DW; Crawford SC; Menezes AH
  • Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice.
    J Neurosurg Volume: 66 Page(s): 584 - 587
    04/01/1987 Authors: Olson JJ; Beck DW; Schlechte JA; Loh PM
  • CORTICOSTEROIDS INHIBIT VASOGENIC EDEMA RESOLUTION
    STROKE Volume: 18 Page(s): 291 - 291
    01/01/1987 Authors: OLSON JJ; BECK DW; WARNER DS
  • Acute effect of angiographic contrast medium on cortical specific gravity after middle cerebral artery occlusion in rats.
    Stroke Volume: 18 Page(s): 924 - 926
    01/01/1987 Authors: Olson JJ; Beck DW; Warner DS
  • Effect of heparin, heparin fragments, and corticosteroids on cerebral endothelial cell growth in vitro and in vivo.
    J Neuropathol Exp Neurol Volume: 45 Page(s): 503 - 512
    09/01/1986 Authors: Beck DW; Olson JJ; Linhardt RJ
  • Glial cells influence membrane-associated enzyme activity at the blood-brain barrier.
    Brain Res Volume: 381 Page(s): 131 - 137
    08/27/1986 Authors: Beck DW; Roberts RL; Olson JJ
  • Percutaneous retrogasserian glycerol rhizotomy for treatment of trigeminal neuralgia.
    J Neurosurg Volume: 65 Page(s): 28 - 31
    07/01/1986 Authors: Beck DW; Olson JJ; Urig EJ
  • Hormonal manipulation of meningiomas in vitro.
    J Neurosurg Volume: 65 Page(s): 99 - 107
    07/01/1986 Authors: Olson JJ; Beck DW; Schlechte J; Loh PM
  • GROWTH-RESPONSE OF MENINGIOMAS TO HORMONAL MODULATION INVITRO
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 45 Page(s): 326 - 326
    05/01/1986 Authors: OLSON JJ; BECK DW; SCHLECHTE J; LOH PM; MACINDOE JW
  • EFFECT OF NEOVASCULARITY ON BLOOD-BRAIN-BARRIER PERMEABILITY
    STROKE Volume: 17 Page(s): 136 - 136
    01/01/1986 Authors: OLSON JJ; BECK DW
  • Primary intracranial rhabdomyosarcoma.
    Neurosurgery Volume: 17 Page(s): 25 - 34
    07/01/1985 Authors: Olson JJ; Menezes AH; Godersky JC; Lobosky JM; Hart M
  • EFFECT OF CORTISONE AND HEPARIN ON DNA-SYNTHESIS IN CEREBRAL ENDOTHELIUM INVITRO
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Volume: 44 Page(s): 341 - 341
    01/01/1985 Authors: OLSON JJ; BECK DW; LINHARDT RJ; HAYS NJ
  • Sarcoidosis presenting as an intramedullary spinal cord mass.
    Neurosurgery Volume: 15 Page(s): 86 - 90
    07/01/1984 Authors: Hitchon PW; Haque AU; Olson JJ; Jacobs SK; Olson SP
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements